x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Delaware | 94-2586591 | |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |
4555 Great America Parkway, 6th Floor, Santa Clara, CA | 95054 | |
(Address of principal executive offices) | (Zip code) |
Large accelerated filer | o | Accelerated filer | x | |||
Non-accelerated filer | o (Do not check if a smaller reporting company) | Smaller reporting company | o |
Page | ||
Part I. | FINANCIAL INFORMATION | |
Item 1. | ||
Item 2. | ||
Item 3. | ||
Item 4. | ||
Part II. | OTHER INFORMATION | |
Item 1. | ||
Item 1A. | ||
Item 2. | ||
Item 3. | ||
Item 4. | ||
Item 5. | ||
Item 6. | ||
June 30, 2016 | March 31, 2016 | |||||||
(unaudited) | * | |||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 24,225 | $ | 25,065 | ||||
Short-term investments | 58,086 | 58,780 | ||||||
Accounts receivable, net | 9,163 | 9,265 | ||||||
Inventories | 12,604 | 16,148 | ||||||
Other current assets | 10,906 | 10,775 | ||||||
Total current assets | 114,984 | 120,033 | ||||||
Property and equipment, net | 13,905 | 13,293 | ||||||
Goodwill | 11,425 | 11,425 | ||||||
Other assets | 1,323 | 1,541 | ||||||
Total assets | $ | 141,637 | $ | 146,292 | ||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ | 6,184 | $ | 8,599 | ||||
Accrued payroll and other accrued liabilities | 4,711 | 4,115 | ||||||
Veloce accrued liability | 6,600 | 6,608 | ||||||
Other accrued liabilities | 11,316 | 9,793 | ||||||
Deferred revenue | 347 | 346 | ||||||
Total current liabilities | 29,158 | 29,461 | ||||||
Non-current liabilities | 1,548 | 1,793 | ||||||
Total liabilities | 30,706 | 31,254 | ||||||
Commitments and contingencies (Note 6) | ||||||||
Stockholders’ equity: | ||||||||
Preferred stock, $0.01 par value: | ||||||||
Authorized shares - 2,000, none issued and outstanding | — | — | ||||||
Common stock, $0.01 par value: | ||||||||
Authorized shares - 375,000 at June 30, 2016 and March 31, 2016 | ||||||||
Issued and outstanding shares - 85,359 at June 30, 2016 and 84,590 at March 31, 2016 | 854 | 846 | ||||||
Additional paid-in capital | 6,065,559 | 6,059,137 | ||||||
Accumulated other comprehensive loss | (9,551 | ) | (9,553 | ) | ||||
Accumulated deficit | (5,945,931 | ) | (5,935,392 | ) | ||||
Total stockholders’ equity | 110,931 | 115,038 | ||||||
Total liabilities and stockholders’ equity | $ | 141,637 | $ | 146,292 |
Three Months Ended June 30, | |||||||
2016 | 2015 | ||||||
Net revenues | $ | 41,498 | $ | 37,813 | |||
Cost of revenues | 16,029 | 16,806 | |||||
Gross profit | 25,469 | 21,007 | |||||
Operating expenses: | |||||||
Research and development | 27,485 | 21,617 | |||||
Selling, general and administrative | 8,699 | 8,764 | |||||
Restructuring | — | 96 | |||||
Total operating expenses | 36,184 | 30,477 | |||||
Operating loss | (10,715 | ) | (9,470 | ) | |||
Realized gain on short-term investments and interest income, net | 230 | 1,619 | |||||
Other income, net | 17 | 25 | |||||
Loss before income taxes | (10,468 | ) | (7,826 | ) | |||
Income tax provision (benefit) | 71 | (422 | ) | ||||
Net loss | $ | (10,539 | ) | $ | (7,404 | ) | |
Basic and diluted net loss per share | $ | (0.12 | ) | $ | (0.09 | ) | |
Shares used in calculating basic and diluted net loss per share | 84,980 | 81,179 |
Three Months Ended June 30, | |||||||
2016 | 2015 | ||||||
Net loss | $ | (10,539 | ) | $ | (7,404 | ) | |
Other comprehensive loss, net of tax: | |||||||
Unrealized gain (loss) on investments* | 147 | (1,653 | ) | ||||
Loss on foreign currency translation | (145 | ) | (137 | ) | |||
Other comprehensive loss, net of tax | 2 | (1,790 | ) | ||||
Total comprehensive loss | $ | (10,537 | ) | $ | (9,194 | ) |
* | The amounts reclassified from accumulated other comprehensive loss and recorded in realized gain on short-term investments and interest income, net in the Condensed Consolidated Statement of Operations related to the sale of short-term investments were $27,000 and $1.4 million for the three months ended June 30, 2016 and 2015, respectively. Refer to Note 2, Certain Financial Statement Information, to the Condensed Consolidated Financial Statements for additional details. |
Three Months Ended June 30, | |||||||
2016 | 2015 | ||||||
Operating activities: | |||||||
Net loss | $ | (10,539 | ) | $ | (7,404 | ) | |
Adjustments to reconcile net loss to net cash provided by operating activities: | |||||||
Depreciation | 1,570 | 1,838 | |||||
Amortization of bond premium | 226 | — | |||||
Stock-based compensation expense | 8,165 | 6,092 | |||||
Gain on short-term investments and other, net | (26 | ) | (1,455 | ) | |||
Tax effect on other comprehensive loss | (94 | ) | — | ||||
Changes in operating assets and liabilities: | |||||||
Accounts receivable | 102 | 882 | |||||
Inventories | 3,552 | 3,723 | |||||
Other assets | (70 | ) | 2,464 | ||||
Accounts payable | (2,382 | ) | (3,453 | ) | |||
Accrued payroll and other accrued liabilities | 1,077 | 220 | |||||
Veloce accrued liability | (8 | ) | (65 | ) | |||
Deferred revenue | 1 | 7 | |||||
Net cash provided by operating activities | 1,574 | 2,849 | |||||
Investing activities: | |||||||
Proceeds from sales and maturities of short-term investments | 18,461 | 7,444 | |||||
Purchases of short-term investments | (17,739 | ) | (1,129 | ) | |||
Proceeds from sale of property and equipment | 2 | 25 | |||||
Purchases of property and equipment | (2,547 | ) | (315 | ) | |||
Net cash provided by (used for) investing activities | (1,823 | ) | 6,025 | ||||
Financing activities: | |||||||
Proceeds from issuance of common stock | 32 | 133 | |||||
Funding of restricted stock units withheld for taxes and other | (623 | ) | (1,212 | ) | |||
Net cash used for financing activities | (591 | ) | (1,079 | ) | |||
Net increase (decrease) in cash and cash equivalents | (840 | ) | 7,795 | ||||
Cash and cash equivalents at beginning of period | 25,065 | 36,495 | |||||
Cash and cash equivalents at end of period | $ | 24,225 | $ | 44,290 | |||
Supplementary cash flow disclosures: | |||||||
Cash paid for income taxes | $ | 167 | $ | 145 | |||
Common stock issued for Veloce merger consideration | $ | — | $ | 921 |
• | capitalized mask sets including their useful lives, which affect cost of goods sold and property and equipment or Research and Development ("R&D") expenses, if not capitalized; |
• | inventory valuation, warranty liabilities and revenue reserves, which affect cost of sales, gross margin, and revenues; |
• | allowance for doubtful accounts, which affects operating expenses; |
• | unrealized losses or other-than-temporary impairments of short-term investments available for sale, which affect interest income (expense), net; |
• | valuation of other long-lived assets and goodwill, which affects depreciation and impairment of long-lived assets, impairment of goodwill and apportionment of goodwill related to divestitures; |
• | potential costs of litigation, which affect operating expenses; |
• | valuation of deferred income taxes, which affects income tax expense (benefit); and |
• | stock-based compensation, which affects gross margin and operating expenses. |
June 30, 2016 | March 31, 2016 | ||||||
(In thousands) | |||||||
Accounts receivable | $ | 9,426 | $ | 9,527 | |||
Less: allowance for bad debts | (263 | ) | (262 | ) | |||
$ | 9,163 | $ | 9,265 |
June 30, 2016 | March 31, 2016 | ||||||
(In thousands) | |||||||
Finished goods | $ | 4,782 | $ | 8,206 | |||
Work in process | 4,836 | 5,854 | |||||
Raw materials | 2,986 | 2,088 | |||||
$ | 12,604 | $ | 16,148 |
June 30, 2016 | March 31, 2016 | ||||||
(In thousands) | |||||||
Prepaid expenses | $ | 8,988 | $ | 8,887 | |||
Executive deferred compensation assets | 837 | 817 | |||||
Other | 1,081 | 1,071 | |||||
$ | 10,906 | $ | 10,775 |
Useful Life | June 30, 2016 | March 31, 2016 | |||||||
(In years) | (In thousands) | ||||||||
Machinery and equipment | 3-5 | $ | 39,632 | $ | 36,723 | ||||
Leasehold improvements | 1-5 | 7,528 | 7,529 | ||||||
Computers, office furniture and equipment | 3-5 | 33,294 | 34,016 | ||||||
80,454 | 78,268 | ||||||||
Less: accumulated depreciation | (66,549 | ) | (64,975 | ) | |||||
$ | 13,905 | $ | 13,293 |
June 30, 2016 | March 31, 2016 | ||||||
(In thousands) | |||||||
Employee related liabilities | $ | 1,563 | $ | 1,362 | |||
Executive deferred compensation | 871 | 848 | |||||
Accrued bonus | 3,921 | 3,269 | |||||
Other | 4,961 | 4,314 | |||||
$ | 11,316 | $ | 9,793 |
June 30, 2016 | March 31, 2016 | ||||||||||||||||||||||||||||||
Amortized Cost | Gross Unrealized | Estimated Fair Value | Amortized Cost | Gross Unrealized | Estimated Fair Value | ||||||||||||||||||||||||||
Gains | Losses | Gains | Losses | ||||||||||||||||||||||||||||
Cash | $ | 21,219 | $ | — | $ | — | $ | 21,219 | $ | 23,510 | $ | — | $ | — | $ | 23,510 | |||||||||||||||
Cash equivalents | 3,006 | — | — | 3,006 | 1,555 | — | — | 1,555 | |||||||||||||||||||||||
U.S. Treasury and agency securities | 14,173 | 74 | — | 14,247 | 14,863 | 38 | (3 | ) | 14,898 | ||||||||||||||||||||||
Corporate bonds | 24,861 | 338 | — | 25,199 | 28,047 | 221 | (5 | ) | 28,263 | ||||||||||||||||||||||
Asset-backed and mortgage-backed securities | 16,701 | 65 | (18 | ) | 16,748 | 13,565 | 13 | (27 | ) | 13,551 | |||||||||||||||||||||
Municipal bonds | 1,877 | 15 | — | 1,892 | 2,052 | 16 | — | 2,068 | |||||||||||||||||||||||
$ | 81,837 | $ | 492 | $ | (18 | ) | $ | 82,311 | $ | 83,592 | $ | 288 | $ | (35 | ) | $ | 83,845 | ||||||||||||||
Reported as: | |||||||||||||||||||||||||||||||
Cash and cash equivalents | $ | 24,225 | $ | 25,065 | |||||||||||||||||||||||||||
Short-term investments available-for-sale | 58,086 | 58,780 | |||||||||||||||||||||||||||||
$ | 82,311 | $ | 83,845 |
June 30, 2016 | March 31, 2016 | |||||||||||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||||||||
Cash | $ | 21,219 | $ | — | $ | — | $ | 21,219 | $ | 23,510 | $ | — | $ | — | $ | 23,510 | ||||||||||||||||
Cash equivalents | 3,006 | — | — | 3,006 | 1,555 | — | — | 1,555 | ||||||||||||||||||||||||
U.S. Treasury and agency securities | 14,247 | — | — | 14,247 | 14,898 | — | — | 14,898 | ||||||||||||||||||||||||
Corporate bonds | — | 25,199 | — | 25,199 | — | 28,263 | — | 28,263 | ||||||||||||||||||||||||
Asset-backed and mortgage-backed securities | — | 16,748 | — | 16,748 | — | 13,551 | — | 13,551 | ||||||||||||||||||||||||
Municipal bonds | — | 1,892 | — | 1,892 | — | 2,068 | — | 2,068 | ||||||||||||||||||||||||
$ | 38,472 | $ | 43,839 | $ | — | $ | 82,311 | $ | 39,963 | $ | 43,882 | $ | — | $ | 83,845 |
June 30, 2016 | ||||||||
Cost | Estimated Fair Value | |||||||
(In thousands) | ||||||||
Less than 1 year | $ | 13,471 | $ | 13,471 | ||||
Mature in 1 – 2 years | 34,118 | 34,386 | ||||||
Mature in 3 – 5 years | 8,823 | 9,023 | ||||||
Mature after 5 years | 1,200 | 1,206 | ||||||
$ | 57,612 | $ | 58,086 |
As of June 30, 2016 | Less Than 12 Months of Unrealized Losses | 12 Months or More of Unrealized Losses | Total | |||||||||||||||||||||
Estimated Fair Value | Gross Unrealized Losses | Estimated Fair Value | Gross Unrealized Losses | Estimated Fair Value | Gross Unrealized Losses | |||||||||||||||||||
Asset-backed and mortgage-backed securities | $ | 4,681 | $ | (18 | ) | $ | — | $ | — | $ | 4,681 | $ | (18 | ) |
As of March 31, 2016 | Less Than 12 Months of Unrealized Losses | 12 Months or More of Unrealized Losses | Total | |||||||||||||||||||||
Estimated Fair Value | Gross Unrealized Losses | Estimated Fair Value | Gross Unrealized Losses | Estimated Fair Value | Gross Unrealized Losses | |||||||||||||||||||
U.S. Treasury and agency securities | $ | 9,396 | $ | (3 | ) | $ | — | $ | — | $ | 9,396 | $ | (3 | ) | ||||||||||
Corporate bonds | 4,601 | (5 | ) | — | — | 4,601 | (5 | ) | ||||||||||||||||
Asset-backed and mortgage-backed securities | 8,394 | (27 | ) | — | — | 8,394 | (27 | ) | ||||||||||||||||
$ | 22,391 | $ | (35 | ) | $ | — | $ | — | $ | 22,391 | $ | (35 | ) |
Foreign currency translation adjustments | Unrealized gain (loss) on short-term investments | Total | |||||||||
(In thousands) | |||||||||||
Balance as of March 31, 2016 | $ | (2,486 | ) | $ | (7,067 | ) | $ | (9,553 | ) | ||
Other comprehensive gain (loss), net of tax | (145 | ) | 147 | 2 | |||||||
Balance as of June 30, 2016 | $ | (2,631 | ) | $ | (6,920 | ) | $ | (9,551 | ) |
Three Months Ended June 30, | |||||||
2016 | 2015 | ||||||
(In thousands) | |||||||
Net realized gain on short-term investments | $ | 32 | $ | 1,430 | |||
Interest income, net | 198 | 189 | |||||
$ | 230 | $ | 1,619 |
June 30, 2016 | June 30, 2015 | ||||
(In thousands) | |||||
Outstanding stock options | 1,384 | 1,713 | |||
Outstanding RSUs | 5,420 | 3,997 | |||
ESPP shares | 383 | 249 | |||
7,187 | 5,959 |
Three Months Ended June 30, | |||||||
2016 | 2015 | ||||||
(In thousands) | |||||||
Cash payments | $ | 8 | $ | 65 | |||
Value of common stock issued | — | 921 | |||||
Total payments | $ | 8 | $ | 986 | |||
Shares of common stock issued | — | 163 |
Number of Shares (thousands) | Weighted Average Exercise Price Per Share | Weighted Average Remaining Contractual Term (years) | Aggregate Intrinsic Value (millions) | ||||||||||||
Outstanding as of March 31, 2016 | 1,571 | $ | 8.92 | ||||||||||||
Granted | — | — | |||||||||||||
Exercised | (6 | ) | $ | 5.23 | — | (1 | ) | ||||||||
Cancelled | (181 | ) | $ | 11.56 | |||||||||||
Outstanding, vested and exercisable as of June 30, 2016 | 1,384 | $ | 8.59 | 0.9 | $ | — | (2 | ) |
Number of Shares (thousands) | Weighted Average Grant Date Fair Value | |||||
Unvested as of March 31, 2016 | 4,704 | $ | 6.59 | |||
Awarded | 1,758 | $ | 6.06 | |||
Vested | (863 | ) | $ | 7.05 | ||
Cancelled | (179 | ) | $ | 5.41 | ||
Unvested as of June 30, 2016 | 5,420 | $ | 6.38 |
Stock-based compensation expense by type of grant: | Three Months Ended June 30, | ||||||
2016 | 2015 | ||||||
(In thousands) | |||||||
Employee stock purchase rights | $ | 327 | $ | 207 | |||
RSUs | 7,847 | 5,897 | |||||
8,174 | 6,104 | ||||||
Stock-based compensation capitalized to inventory | (9 | ) | (12 | ) | |||
Total | $ | 8,165 | $ | 6,092 |
Stock-based compensation expense by cost centers: | Three Months Ended June 30, | ||||||
2016 | 2015 | ||||||
(In thousands) | |||||||
Cost of revenues | $ | 167 | $ | 105 | |||
Research and development | 5,993 | 4,060 | |||||
Selling, general and administrative | 2,014 | 1,939 | |||||
8,174 | 6,104 | ||||||
Stock-based compensation capitalized to inventory | (9 | ) | (12 | ) | |||
Total | $ | 8,165 | $ | 6,092 |
Fiscal Years Ending March 31, | Operating Leases | Purchase Commitments * | Total | ||||||||
2017 (remainder of year) | $ | 1,849 | $ | 21,465 | $ | 23,314 | |||||
2018 | 871 | 11,194 | 12,065 | ||||||||
2019 | 503 | 378 | 881 | ||||||||
Total | $ | 3,223 | $ | 33,037 | $ | 36,260 |
Three Months Ended June 30, | |||||
2016 | 2015 | ||||
Wintec (global logistics provider)** | 26 | % | 29 | % | |
Avnet (distributor) | 32 | % | 25 | % | |
Arrow (distributor) | * | 11 | % | ||
Flextronics (contract manufacturer) | * | 11 | % |
* | Less than 10% of total net revenues for period indicated. |
** | Wintec provides vendor managed inventory support primarily for Cisco Systems, Inc. |
Three Months Ended June 30, | |||||||
2016 | 2015 | ||||||
(In thousands) | |||||||
United States of America | $ | 18,239 | $ | 18,044 | |||
Taiwan | 2,649 | 1,314 | |||||
Hong Kong | 9,343 | 5,971 | |||||
Europe | 5,891 | 7,392 | |||||
Japan | 3,846 | 3,813 | |||||
Other | 1,530 | 1,279 | |||||
$ | 41,498 | $ | 37,813 |
ITEM 2. | MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS |
• | Caution concerning forward-looking statements. This section discusses how forward-looking statements made by us in the MD&A and elsewhere in this quarterly report are based on management’s present expectations about future events and are inherently susceptible to uncertainty and changes in circumstances. |
• | Overview. This section provides an introductory overview and context for the discussion and analysis that follows in the MD&A. |
• | Critical accounting policies. This section discusses those accounting policies that are both considered important to our financial condition and operating results and require significant judgment and estimates on the part of management in their application. |
• | Results of operations. This section provides an analysis of our results of operations for the three months ended June 30, 2016 and 2015. A brief description is provided of transactions and events that impact the comparability of the results being analyzed. |
• | Liquidity and capital resources. This section provides an analysis of our cash position and cash flows, as well as a discussion of our financing arrangements and financial commitments. |
Three Months Ended June 30, | ||||||||||||||||||||
2016 | 2015 | |||||||||||||||||||
Amount | % of Net Revenue | Amount | % of Net Revenue | Increase (Decrease) | % Change | |||||||||||||||
Net revenues | $ | 41,498 | 100.0 | % | $ | 37,813 | 100.0 | % | $ | 3,685 | 9.7 | % | ||||||||
Cost of revenues | 16,029 | 38.6 | 16,806 | 44.4 | (777 | ) | (4.6 | )% | ||||||||||||
Gross profit | 25,469 | 61.4 | 21,007 | 55.6 | 4,462 | 21.2 | % | |||||||||||||
Total operating expenses | 36,184 | 87.2 | 30,477 | 80.6 | 5,707 | 18.7 | % | |||||||||||||
Operating loss | (10,715 | ) | (25.8 | ) | (9,470 | ) | (25.0 | ) | 1,245 | 13.1 | % | |||||||||
Realized gain on short-term investments and interest and other income, net | 247 | 0.6 | 1,644 | 4.3 | (1,397 | ) | (85.0 | )% | ||||||||||||
Loss before income taxes | (10,468 | ) | (25.2 | ) | (7,826 | ) | (20.7 | ) | 2,642 | 33.8 | % | |||||||||
Income tax provision | 71 | 0.2 | (422 | ) | (1.1 | ) | 493 | (116.8 | )% | |||||||||||
Net loss | $ | (10,539 | ) | (25.4 | )% | $ | (7,404 | ) | (19.6 | )% | $ | 3,135 | 42.3 | % |
Three Months Ended June 30, | |||||
2016 | 2015 | ||||
Wintec (global logistics provider)** | 26 | % | 29 | % | |
Avnet (distributor) | 32 | % | 25 | % | |
Arrow (distributor) | * | 11 | % | ||
Flextronics (contract manufacturer) | * | 11 | % |
* | Less than 10% of total net revenues for period indicated. |
** | Wintec provides vendor managed inventory support primarily for Cisco Systems, Inc. |
Three Months Ended June 30, | |||||||||||||
2016 | 2015 | ||||||||||||
Amount | % of Net Revenue | Amount | % of Net Revenue | ||||||||||
United States of America | $ | 18,239 | 44.0 | % | $ | 18,044 | 47.7 | % | |||||
Taiwan | 2,649 | 6.4 | 1,314 | 3.5 | |||||||||
Hong Kong | 9,343 | 22.5 | 5,971 | 15.8 | |||||||||
Europe | 5,891 | 14.2 | 7,392 | 19.5 | |||||||||
Japan | 3,846 | 9.3 | 3,813 | 10.1 | |||||||||
Other | 1,530 | 3.6 | 1,279 | 3.4 | |||||||||
$ | 41,498 | 100.0 | % | $ | 37,813 | 100.0 | % |
Three Months Ended June 30, | |||||||||||||||||||||
2016 | 2015 | ||||||||||||||||||||
Amount | % of Net Revenue | Amount | % of Net Revenue | Increase | % Change | ||||||||||||||||
Computing | $ | 16,453 | 39.6 | % | $ | 14,517 | 38.4 | % | $ | 1,936 | 13.3 | % | |||||||||
Connectivity | 25,045 | 60.4 | 23,296 | 61.6 | 1,749 | 7.5 | % | ||||||||||||||
Total | $ | 41,498 | 100.0 | % | $ | 37,813 | 100.0 | % | $ | 3,685 | 9.7 | % |
Three Months Ended June 30, | |||||||||||||||||||||
2016 | 2015 | ||||||||||||||||||||
Amount | % of Net Revenue | Amount | % of Net Revenue | Increase (Decrease) | % Change | ||||||||||||||||
Net revenues | $ | 41,498 | 100.0 | % | $ | 37,813 | 100.0 | % | $ | 3,685 | 9.7 | % | |||||||||
Cost of revenues | 16,029 | 38.6 | 16,806 | 44.4 | (777 | ) | (4.6 | )% | |||||||||||||
Gross profit | $ | 25,469 | 61.4 | % | $ | 21,007 | 55.6 | % | $ | 4,462 | 21.2 | % |
Three Months Ended June 30, | |||||||||||||||||||||
2016 | 2015 | ||||||||||||||||||||
Amount | % of Net Revenue | Amount | % of Net Revenue | Increase (Decrease) | % Change | ||||||||||||||||
Research and development | $ | 27,485 | 66.2 | % | $ | 21,617 | 57.2 | % | $ | 5,868 | 27.1 | % | |||||||||
Selling, general and administrative | $ | 8,699 | 21.0 | % | $ | 8,764 | 23.2 | % | $ | (65 | ) | (0.7 | )% |
Three Months Ended June 30, | |||||||||||||||||||||
2016 | 2015 | ||||||||||||||||||||
Amount | % of Net Revenue | Amount | % of Net Revenue | Increase (Decrease) | % Change | ||||||||||||||||
Realized gain on short-term investments and interest income, net | $ | 230 | 0.6 | % | $ | 1,619 | 4.3 | % | $ | (1,389 | ) | (85.8 | )% |
Three Months Ended June 30, | |||||||
2016 | 2015 | ||||||
(In thousands) | |||||||
Net cash provided by operating activities | $ | 1,574 | $ | 2,849 | |||
Net cash provided by (used for) investing activities | (1,823 | ) | 6,025 | ||||
Net cash used for financing activities | (591 | ) | (1,079 | ) | |||
Net increase (decrease) in cash and cash equivalents | $ | (840 | ) | $ | 7,795 |
ITEM 3. | QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK |
Valuation of Securities Given an Interest Rate Decrease of X Basis Points (“BPS”) | Fair Value as of | Valuation of Securities Given an Interest Rate Increase of X Basis Points (“BPS”) | ||||||||||||||||||||||||||
(150 BPS) | (100 BPS) | (50 BPS) | June 30, 2016 | 50 BPS | 100 BPS | 150 BPS | ||||||||||||||||||||||
Available-for-sale investments | $ | 59,532 | $ | 59,158 | $ | 58,657 | $ | 58,086 | $ | 57,523 | $ | 56,969 | $ | 56,422 |
ITEM 4. | CONTROLS AND PROCEDURES |
ITEM 1. | LEGAL PROCEEDINGS |
ITEM 1A. | RISK FACTORS |
• | the scale and depth of our R&D, sales and marketing budgets and related resources, as compared to our competitors, and our ability to increase our scale sufficient to more effectively compete with them; |
• | our ability to partner with original equipment manufacturer ("OEM"), ecosystem and channel partners who are successful in the market; |
• | success in designing and subcontracting the manufacture of new products that implement new technologies; |
• | product quality, interoperability, reliability, performance and certification; |
• | procurement expenses, supply chain economies of scale, and production efficiency, as compared to our larger competitors: |
• | our ability to attract and retain key engineering, operations, sales and marketing employees and management; |
• | pricing decisions or other actions taken by competitors; |
• | customer support; |
• | time-to-market; |
• | price; |
• | production efficiency; |
• | design wins; |
• | expansion of production of our products for particular systems manufacturers; |
• | end-user acceptance of the systems manufacturers' products; |
• | market acceptance of competitors' products; and |
• | general economic conditions. |
• | our customers’ willingness to incorporate products based on the ARM architecture, on which most of our new products are based, into their own products and systems; |
• | our successful collaboration with our ecosystem and technology partners; |
• | availability, quality, price, performance, power consumption, size and total cost of ownership of our products relative to competing products and technologies; |
• | our accurate prediction of changing customer requirements; |
• | the sufficiency and scale of our R&D budget and our timely development of new designs; |
• | retention of key technical and design expertise, both internally and within third-party technology development partners; |
• | timely qualification and certification of our products for use in electronic systems; |
• | continued availability on commercially reasonable terms of the manufacturing services, technology components and tools that we purchase or license from third party suppliers; |
• | commercial acceptance and production of the electronic systems into which our products are incorporated; |
• | our customer service and support capabilities and responsiveness; |
• | successful development of relationships with existing and potential new customers; |
• | maintaining compliance and compatibility with new and changing industry standards and requirements; |
• | maintaining close working relationships with key customers so that they will design our products into their future products; and |
• | our ability to develop, gain access to and use leading technologies in a cost-effective and timely manner. |
• | pricing of foundry services and of other supply chain services such as assembly, packaging and testing, from vendors such as Taiwan Semiconductor Manufacturing Company Ltd., GlobalFoundries, Inc. (which recently took over foundry services previously provided to us by International Business Machines Corporation), Advanced Semiconductor Engineering, Inc. and Siliconware Precision Industries Co., Ltd.; |
• | reduced control over the supply chain process, delivery schedules and quality; |
• | potentially inadequate manufacturing yields and excessive costs; |
• | the risks associated with transitioning our manufacturing supply from one foundry or other supplier to another, which may be extremely difficult to accomplish, particularly on short notice and when cutting-edge process technologies are involved; |
• | our ability to retain key personnel with specialized knowledge of our products and processes; |
• | difficulties selecting and integrating new subcontractors; |
• | the potential lack of adequate capacity at the foundry during periods of high demand, resulting in significant increases in lead time requirements and production delays, which can be expected to cause difficulties with our customers, including reduced revenues and higher expenses; |
• | increased risk of excess and obsolete inventory charges due to the higher level of inventories in response to the increased lead times; |
• | limited warranties on products supplied to us, which may not match the warranties that our customers require from us; |
• | potential instability and business disruption in countries where third-party manufacturers or distributors are located; |
• | potential misappropriation of our IP; |
• | the speed, efficiency and success with which our outside foundries and suppliers are able to transition to the next generation of manufacturing technologies and to smaller geometries; and |
• | potential foundry shortages when we commence volume manufacturing of new products, especially those with 28nm, 16nm and anticipated smaller geometry technologies or using more complicated manufacturing process technologies such as FinFET, which could delay the supply of products to our customers. |
• | market acceptance of our products and our customers' products, including without limitation any failure of our X-Gene, X-Weave or HeliX product families to be commercially accepted within the time frames and at the levels we anticipate; |
• | the reduction, rescheduling or cancellation of orders by customers, including without limitation as a result of slowing demand for our products or our customers' products, over-ordering or double booking of our products or our customers' products, or agreements with customers to accelerate, delay, increase or decrease previously anticipated orders; |
• | changes to U.S. or other applicable export laws or the imposition of trade embargoes or other restrictions, which may delay, limit or prohibit our sale or resale of products and technologies to certain countries or customers; |
• | changes in the timing and amounts of shipments due to our decision to phase out a particular product, which often results in near-term “last-time-buy” orders for the “end-of-life” product that would otherwise have been placed and shipped in later periods; |
• | changes in the mix of product orders; |
• | the gain or loss of one or more key customers or their key customers, or significant changes in the financial condition of one or more of our key customers or their key customers; |
• | our ability to introduce, certify and deliver new products and technologies, including without limitation the next generation of our X-Gene, X-Weave and HeliX products, on a timely basis; |
• | the announcement or introduction of new products and technologies by our competitors; |
• | competitive pressures on selling prices; |
• | the ability of our customers to obtain components from their other suppliers; |
• | risks associated with our or our customers' dependence on third-party manufacturing and supply relationships; |
• | increases in the costs of facilities leases, in particular for our headquarters facilities lease which expires in 2017, and other material contracts with our service providers: |
• | increases in the costs of our ARM instruction set architecture or other technology licenses or our failure to renew such licenses; |
• | increases in the costs of mask sets and other manufacturing materials and services, including without limitation with respect to smaller or more sophisticated process technologies such as FinFET, or the discontinuance of products, services or components by our suppliers; |
• | the amounts and timing of meeting the specifications and expense recovery on non-recurring engineering projects; |
• | the amounts and timing of costs associated with warranties, product returns and customer indemnification claims; |
• | the impact of potential claims asserting infringement of third party patent or misappropriation of third party IP rights; |
• | the amounts and timing of investments in R&D; |
• | the product lifecycle and recoverability of architectural licenses, technology access fees and mask set costs; |
• | revenue and margin fluctuations depending on the timing and amount of any IP licensing or sale transactions that we may undertake; |
• | the amounts and timing of the costs associated with payroll taxes related to stock option exercises or settlement of restricted stock units; |
• | the impact of potential one-time charges related to goodwill; |
• | our ability to use net operating losses (“NOLs”) to offset taxable income and the potential restrictions placed on our use of such NOLs that could result from changes to existing tax laws or to our shareholder ownership profile: |
• | the impact on interest income of a significant use of our cash for an acquisition, stock repurchase or other purpose; |
• | the effects of changes in interest rates or credit worthiness on the value and yield of our short-term investment portfolio; |
• | the effects of changes in accounting standards; and |
• | the availability of ecosystem partners. |
• | shortages of raw materials or production capacity constraints that lead our suppliers to allocate available supplies or capacity to their other customers, which may disrupt our ability to meet our production obligations; |
• | our customers experiencing shortages from their suppliers, which may cause them to delay orders or deliveries of our products; |
• | delays in the availability of the software elements from third party vendors and ecosystem partners that may cause delays in customers' use of our hardware products, resulting in further delays in bringing our products to market; |
• | the reduction, rescheduling or cancellation of customer orders, including without limitation agreements with customers to delay the timing or decrease the size of orders, resulting in decreased near-term revenues from the affected products, or to accelerate the timing or increase the size of orders, resulting in reduced revenues from those products in later periods; |
• | declines in the average selling prices of our products; |
• | delays in the introduction of new products, or lower than expected demand for new products; |
• | delays when our customers are transitioning from old architectures, technologies and products to new architectures, technologies and products; |
• | a decrease in demand for our products or our customers' products due to technological changes, industry consolidation, competitive developments, trends in our customers’ businesses or other factors; |
• | a decline in the financial condition or liquidity of our customers or their customers; |
• | the failure of our products to be qualified in our customers' systems or certified by our customers; |
• | excess inventory of our products held by our customers, resulting in a reduction in their order patterns as they work through such excess inventory; |
• | decisions to phase out or “end-of-life” particular products, which may result in higher near-term revenues due to customers’ final, “last-time-buy” orders, but a cessation of revenues from those products in later periods; |
• | fabrication, test, product yield, or assembly constraints for our products that adversely affect our ability to meet our production obligations; |
• | the failure of one or more of our subcontract manufacturers to perform its obligations to us; |
• | our failure to successfully integrate or maintain acquired companies, products and technologies; and |
• | global political, economic and industry conditions. |
Three Months Ended June 30, | |||||
2016 | 2015 | ||||
Wintec (global logistics provider)** | 26 | % | 29 | % | |
Avnet (distributor) | 32 | % | 25 | % | |
Arrow (distributor) | * | 11 | % | ||
Flextronics (contract manufacturer) | * | 11 | % |
• | customers may stop incorporating our products into their own products with limited notice to us; |
• | customers or prospective customers may not incorporate our products into their future product designs; |
• | the timing and success of new product introductions by customers; |
• | some of our customers may reduce or eliminate future purchase orders or design wins placed with us as an adverse reaction to our having sold patents to third parties who thereafter asserted the acquired patents in infringement actions brought against such customers, or due to other adverse IP developments; |
• | sales of customer product lines incorporating our products may rapidly decline or such product lines may be phased out; |
• | our agreements with customers typically are non-exclusive and do not require them to purchase a minimum quantity of our products; |
• | many of our customers have pre-existing relationships or may establish relationships with our current or potential competitors that may delay or deter such customers from adopting our products or may cause them to switch from using our products to using competing products; |
• | some of our OEM customers may develop products internally that would replace our products; |
• | we may not be able to successfully develop relationships with additional network equipment vendors; |
• | our relationships with some of our larger customers may deter other potential customers (who compete with these customers) from buying our products; and |
• | the impact of terminating certain sales or support personnel as a result of our workforce reduction or otherwise. |
• | diversion of management's attention from our core businesses; |
• | both expected and unanticipated adverse effects from the loss of technologies, patents and other IP and personnel relating to divested subsidiaries, product lines and businesses; |
• | adverse effects on existing business relationships with suppliers and customers and on employee morale; |
• | costs associated with acquisitions, investments and divestitures; |
• | difficulties associated with combining, integrating or separating acquired or divested operations, products or technologies; |
• | failure to integrate or potential loss of key employees, particularly those of the acquired companies; |
• | potential difficulties resulting from the divestiture of business operations, with respect to protecting the confidentiality of proprietary information and trade secrets not subject to the divestiture; |
• | difficulties and risks associated with the methods, estimates and judgments we use in applying critical accounting policies, such as the methods and judgments we used in valuing the Veloce merger consideration, which affected our R&D expense in certain periods in fiscal 2014 and 2015; |
• | difficulty in completing an acquired company's in-process research or development projects; |
• | difficulties and risks associated with entering and competing in markets that are unfamiliar to us; |
• | the ability of the acquired companies to meet their financial projections; and |
• | the effect of divesting subsidiaries, product families or businesses on our revenues and margins. |
• | issue stock that would dilute, in some cases significantly, our current stockholders' percentage ownership; |
• | use a significant portion of our cash reserves or incur debt; |
• | assume liabilities, including unanticipated third-party litigation and other unknown liabilities and unanticipated costs, events or circumstances; |
• | incur adverse tax consequences; |
• | incur amortization or impairment expenses related to goodwill and other intangible assets, depreciation and deferred compensation; and |
• | incur large one-time charges and immediate write-offs. |
• | foreign currency exchange fluctuations to the extent that this impacts our customers' purchasing power; |
• | changes in regulatory requirements; |
• | tariffs, rising protectionism and other trade barriers; |
• | timing and availability of export licenses, as well as barriers to direct sales or resales to specified customers or jurisdictions outside the U.S.; |
• | political and economic instability; |
• | natural disasters; |
• | increased exposure to liability under U.S and foreign anti-corruption laws and regulations; |
• | difficulties in staffing and managing foreign operations; |
• | difficulties in managing distributors; |
• | reduced or uncertain protection for IP rights in some countries; |
• | longer payment cycles and difficulties in collecting accounts receivable in some countries; |
• | burdens of complying with a wide variety of complex foreign laws and treaties; |
• | potentially adverse tax consequences; and |
• | uncertain economic conditions that may worsen or sustain improvements which trail those in the U.S. |
• | delays in development, manufacture and roll-out of new products; |
• | additional development costs; |
• | loss of, or delays in, market acceptance; |
• | diversion of technical and other resources from our other development efforts; |
• | claims by our customers or others against us; and |
• | loss of credibility with our current and prospective customers. |
• | Any such event could have a material adverse effect on our business, financial condition and results of operations. |
• | having information about our products and technologies subpoenaed, and our employees deposed, in patent litigation between other third parties; |
• | demands that we enter into expensive licenses of third party patent portfolios in order to avoid being named as a defendant in future IP infringement suits; |
• | claims, contractual or otherwise, demanding that we indemnify or reimburse customers or end users of our products |
• | demands from customers that we enter into “springing licenses” that prospectively grant such customers and related parties automatic license rights to any patents we sell or otherwise divest control over in specified transactions. |
• |
• | fluctuations in our anticipated or actual operating results; |
• | our announcement of actual results or financial outlook that are higher or lower than market or analyst expectations; |
• | changes in the economic performance or market valuations of other semiconductor companies or companies perceived by investors to be comparable to us; |
• | announcements or introductions of new products by us or our competitors; |
• | fluctuations in the anticipated or actual operating results or growth rates of our customers, peers or competitors; |
• | technological innovations or setbacks by us or our competitors; |
• | conditions in the semiconductor, communications or IT markets; |
• | the commencement or outcome of litigation or governmental investigations; |
• | changes in ratings and estimates of our performance, or loss of coverage, by securities analysts; |
• | positive or negative commentary about our business or prospects by industry bloggers and journalists; |
• | volume fluctuations due to inconsistent trading volume levels of our shares; |
• | announcements, by us or third parties, of merger, acquisition or financing transactions; |
• | management changes; |
• | our inclusion in certain stock indices; and |
• | general economic and market conditions. |
• | the ability of the board of directors to issue up to 2.0 million shares of “blank check” preferred stock with terms designed to prevent or delay a takeover attempt, as described further below; |
• | the prohibition of cumulative voting in the election of directors, which would otherwise allow less than a majority of stockholders to elect director candidates; |
• | the requirement for advance notice for nominations of directors for election to the board or for proposing matters that can be acted upon at a stockholders' meeting; |
• | the ability of the board of directors to alter our bylaws without obtaining stockholder approval; |
• | the requirement that any stockholder derivative actions and certain other intra-corporate disputes be litigated solely and exclusively in Delaware state court; |
• | the right of the board of directors to elect a director to fill a vacancy created by the expansion of the board of directors; and |
• | the prohibition of the right of stockholders to call a special meeting of stockholders. |
ITEM 2. | UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS |
Period | Total Number of Shares Repurchased | Average Price Per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | Maximum Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased Under the Plans or Programs | ||||||
April 1, 2016 - April 30, 2016 | 10,084 | $ | 6.42 | N/A | N/A | |||||
May 1, 2016 - May 31, 2016 | — | — | N/A | N/A | ||||||
June 1, 2016 - June 30, 2016 | — | — | N/A | N/A | ||||||
Total | 10,084 | $ | 6.42 | N/A | N/A |
ITEM 3. | DEFAULTS UPON SENIOR SECURITIES |
ITEM 4. | MINE SAFETY DISCLOSURES |
ITEM 5. | OTHER INFORMATION |
ITEM 6. | EXHIBITS |
APPLIED MICRO CIRCUITS CORPORATION | |||
By: | /S/ Martin S. McDermut | ||
Martin S. McDermut | |||
Vice President and Chief Financial Officer | |||
(Duly Authorized Signatory and Principal Financial and Accounting Officer) |
Incorporated by Reference | |||||||||||
Exhibit Number | Exhibit Description | Form | Filing Date | Exhibit Number | Filed Herewith | ||||||
3.1 | Amended and Restated Certificate of Incorporation of the Company. | S-1 | 10/10/1997 | 3.2 | |||||||
3.2 | Certificate of Amendment of Certificate of Incorporation of the Company. | S-4 | 9/12/2000 | 3.3 | |||||||
3.3 | Certificate of Amendment of Certificate of Incorporation of the Company. | 8-K | 12/11/2007 | 3.1 | |||||||
3.4 | Amended and Restated Bylaws of the Company. | 10-Q | 11/3/2010 | 3.2 | |||||||
4.1 | Specimen Stock Certificate. | S-1/A | 11/12/1997 | 4.1 | |||||||
31.1 | Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act, as amended. | x | |||||||||
31.2 | Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act, as amended. | x | |||||||||
32.1 | Certification of Chief Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | x | |||||||||
32.2 | Certification of Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | x | |||||||||
101.INS | XBRL Instance Document | x | |||||||||
101.SCH | XBRL Taxonomy Extension Schema Document | x | |||||||||
101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document | x | |||||||||
101.DEF | XBRL Taxonomy Extension Definition Linkbase Document | x | |||||||||
101.LAB | XBRL Taxonomy Extension Label Linkbase Document | x | |||||||||
101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document | x |
(a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
(b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
(c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
(d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
(a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
(b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
/s/ Paramesh Gopi |
Dr. Paramesh Gopi |
President and Chief Executive Officer |
(a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
(b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
(c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
(d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
(a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
(b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
/S/ Martin S. McDermut |
Martin S. McDermut |
Vice President and Chief Financial Officer |
1. | This Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2016 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). |
2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
/s/ Paramesh Gopi |
Dr. Paramesh Gopi |
President and Chief Executive Officer |
1. | This Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2016 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). |
2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
/S/ Martin S. McDermut |
Martin S. McDermut |
Vice President and Chief Financial Officer |
Document and Entity Information - shares |
3 Months Ended | |
---|---|---|
Jun. 30, 2016 |
Jul. 29, 2016 |
|
Document and Entity Information [Abstract] | ||
Entity Registrant Name | APPLIED MICRO CIRCUITS CORP | |
Entity Central Index Key | 0000711065 | |
Document Type | 10-Q | |
Amendment Flag | false | |
Document Period End Date | Jun. 30, 2016 | |
Document Fiscal Year Focus | 2017 | |
Document Fiscal Period Focus | Q1 | |
Current Fiscal Year End Date | --03-31 | |
Entity Filer Category | Accelerated Filer | |
Entity Common Stock, Shares Outstanding | 85,366,236 |
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares |
Jun. 30, 2016 |
Mar. 31, 2016 |
---|---|---|
Statement of Financial Position [Abstract] | ||
Preferred stock, par value (in Dollars per share) | $ 0.01 | $ 0.01 |
Preferred stock, shares authorized (shares) | 2,000,000 | 2,000,000 |
Preferred stock, shares issued (shares) | 0 | 0 |
Preferred stock, shares outstanding (shares) | 0 | 0 |
Common stock, par value (in Dollars per share) | $ 0.01 | $ 0.01 |
Common stock, shares authorized (shares) | 375,000,000 | 375,000,000 |
Common stock, shares issued (shares) | 85,359,000 | 84,590,000 |
Common stock, shares outstanding (shares) | 85,359,000 | 84,590,000 |
Condensed Consolidated Statements of Operations (unaudited) - USD ($) shares in Thousands, $ in Thousands |
3 Months Ended | |
---|---|---|
Jun. 30, 2016 |
Jun. 30, 2015 |
|
Income Statement [Abstract] | ||
Net revenues | $ 41,498 | $ 37,813 |
Cost of revenues | 16,029 | 16,806 |
Gross profit | 25,469 | 21,007 |
Operating expenses: | ||
Research and development | 27,485 | 21,617 |
Selling, general and administrative | 8,699 | 8,764 |
Restructuring | 0 | 96 |
Total operating expenses | 36,184 | 30,477 |
Operating loss | (10,715) | (9,470) |
Realized gain on short-term investments and interest income, net | 230 | 1,619 |
Other income, net | 17 | 25 |
Loss before income taxes | (10,468) | (7,826) |
Income tax provision (benefit) | 71 | (422) |
Net loss | $ (10,539) | $ (7,404) |
Basic and diluted net loss per share (in dollars per share) | $ (0.12) | $ (0.09) |
Shares used in calculating basic and diluted net loss per share (in shares) | 84,980 | 81,179 |
Condensed Consolidated Statements of Comprehensive Loss (unaudited) - USD ($) $ in Thousands |
3 Months Ended | |||
---|---|---|---|---|
Jun. 30, 2016 |
Jun. 30, 2015 |
|||
Statement of Comprehensive Income [Abstract] | ||||
Net loss | $ (10,539) | $ (7,404) | ||
Other comprehensive loss, net of tax: | ||||
Unrealized gain (loss) on investments | [1] | 147 | (1,653) | |
Loss on foreign currency translation | (145) | (137) | ||
Other comprehensive loss, net of tax | 2 | (1,790) | ||
Total comprehensive loss | $ (10,537) | $ (9,194) | ||
|
Condensed Consolidated Statements of Comprehensive Loss (unaudited) (Parenthetical) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Jun. 30, 2016 |
Jun. 30, 2015 |
|
Statement of Comprehensive Income [Abstract] | ||
Reclassification adjustment from AOCI to earnings, short term investments | $ 27 | $ 1,400 |
Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Thousands |
3 Months Ended | ||||
---|---|---|---|---|---|
Jun. 30, 2016 |
Jun. 30, 2015 |
||||
Adjustments to reconcile net loss to net cash provided by operating activities: | |||||
Net loss | $ (10,539) | $ (7,404) | |||
Depreciation | 1,570 | 1,838 | |||
Amortization of bond premium | 226 | 0 | |||
Stock-based compensation expense | 8,165 | 6,092 | |||
Gain on short-term investments and other, net | (26) | (1,455) | |||
Tax effect on other comprehensive loss | (94) | 0 | |||
Changes in operating assets and liabilities: | |||||
Accounts receivable | 102 | 882 | |||
Inventories | 3,552 | 3,723 | |||
Other assets | (70) | 2,464 | |||
Accounts payable | (2,382) | (3,453) | |||
Accrued payroll and other accrued liabilities | 1,077 | 220 | |||
Veloce accrued liability | (8) | (65) | |||
Deferred revenue | 1 | 7 | |||
Net cash provided by operating activities | 1,574 | 2,849 | |||
Investing activities: | |||||
Proceeds from sales and maturities of short-term investments | 18,461 | 7,444 | |||
Purchases of short-term investments | (17,739) | (1,129) | |||
Proceeds from sale of property and equipment | 2 | 25 | |||
Purchases of property and equipment | (2,547) | (315) | |||
Net cash provided by (used for) investing activities | (1,823) | 6,025 | |||
Financing activities: | |||||
Proceeds from issuance of common stock | 32 | 133 | |||
Funding of restricted stock units withheld for taxes and other | (623) | (1,212) | |||
Net cash used for financing activities | (591) | (1,079) | |||
Net increase (decrease) in cash and cash equivalents | (840) | 7,795 | |||
Cash and cash equivalents at beginning of period | 25,065 | [1] | 36,495 | ||
Cash and cash equivalents at end of period | 24,225 | 44,290 | |||
Supplementary cash flow disclosures: | |||||
Cash paid for income taxes | 167 | 145 | |||
Common stock issued for Veloce merger consideration | $ 0 | $ 921 | |||
|
Summary of Significant Accounting Policies |
3 Months Ended | ||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2016 | |||||||||||||||||||||||||||||||||
Accounting Policies [Abstract] | |||||||||||||||||||||||||||||||||
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Overview Applied Micro Circuits Corporation (the "Company") is a global leader in silicon solutions for next-generation cloud infrastructure and data centers, as well as connectivity products for edge, metro and long-haul communications equipment. Basis of Presentation The Condensed Consolidated Financial Statements include all the accounts of the Company's and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. The Company prepared the accompanying unaudited Condensed Consolidated Financial Statements pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). In management’s opinion, the unaudited Condensed Consolidated Financial Statements reflect all adjustments (consisting only of normal recurring adjustments) necessary to fairly present the Company's financial position, results of operations and cash flows. Interim period operating results do not necessarily indicate the results that may be expected for any other interim period or for the full fiscal year. These financial statements and accompanying notes should be read in conjunction with the Consolidated Financial Statements and notes thereto in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2016. Use of Estimates The preparation of financial statements in accordance with U.S. generally accepted accounting principles ("GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of net revenue and expenses in the reporting period. The Company regularly evaluates estimates and assumptions related to its:
The Company bases its estimates and assumptions on historical experience and on various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from management’s estimates. To the extent there are material differences between the estimates and actual results, future results of operations will be affected. Risks and Uncertainties The Company's future results of operations involve a number of risks and uncertainties. Factors that could affect the Company's business or future results and cause actual results to vary materially from historical results include, but are not limited to, the highly cyclical nature of the semiconductor industry; high fixed costs; declines in average selling prices; ability to fund liquidity needs; failure to maintain an effective system of internal controls; product return and liability risks; absence of significant backlog; dependence on international operations and sales; proposed changes to United States tax laws which result in adverse tax consequences; inadequate management information systems; ability to attract and retain qualified employees; difficulties consolidating and evolving the operational capabilities; dependence on materials and equipment suppliers; loss of customers; development of new proprietary technology and the enforcement of intellectual property ("IP") rights by or against the Company; the complexity of packaging and test processes; competition; existing and future environmental regulations; and fire, flood or other calamities affecting the Company or others with whom it does business. The Company's cash, cash equivalents, short-term investments and accounts receivable are potentially subject to concentration of credit risk. Cash and cash equivalents may be redeemable upon demand and are maintained with several financial institutions that management believes are of high credit quality and therefore bear minimal credit risk. The Company's accounts receivables are derived from revenue earned from customers located around the world. Two customers accounted for 80% and 69% of accounts receivable at June 30, 2016 and March 31, 2016, respectively. This concentration and the concentration of credit risk resulting from trade receivables is substantially mitigated by the credit evaluation process and collateral. The Company sells its products primarily through direct sales force and distributors. Based on direct shipments, 2 and 4 customers individually accounted for at least 10% of total net revenues during the three months ended June 30, 2016 and 2015, respectively. The Company expects that its largest customers collectively will continue to account for a substantial portion of its net revenue for the foreseeable future. See Note 7, Significant Customer and Geographic Information, to the Condensed Consolidated Financial Statements for details. The Company currently purchases wafers from a limited number of vendors. Additionally, since the Company does not maintain manufacturing facilities, it depends upon close relationships with contract manufacturers to assemble its products. The Company anticipates the continued use of a limited number of vendors and contract manufacturers in the near future. Under the Company's fabless business model, long-term revenue growth is dependent on its ability to obtain sufficient external manufacturing capacity, including wafer production. The Company believes there are other vendors that can provide the same quality wafers at competitive prices and other contract manufacturers that can provide comparable services at competitive prices. New Accounting Pronouncements In March 2016, the FASB issued ASU No. 2016-09, "Stock Compensation (Topic 718); Improvements to Employee Share-Based Payment Accounting". The new guidance simplifies several aspects of the accounting for share-based payment transactions including the income tax consequences, classification of awards as either equity or liabilities, policy election to account for forfeitures as they occur rather than on an estimated basis, and classification on the statement of cash flows. The ASU is effective for annual periods beginning after December 15, 2016, including interim periods within that reporting period. Early adoption is permitted. The Company has adopted this ASU as of June 30, 2016. The adoption of this accounting standard was not material to the Company’s Condensed Consolidated Financial Statements and related disclosures. |
Certain Financial Statement Information |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Certain Financial Statement Information [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CERTAIN FINANCIAL STATEMENT INFORMATION | CERTAIN FINANCIAL STATEMENT INFORMATION Accounts receivable, net:
Inventories:
Other current assets:
Property and equipment:
Other accrued liabilities:
Short-term investments: The following is a summary of cash, cash equivalents and available-for-sale investments by type of instrument (in thousands):
The established guidelines for measuring fair value and expanded disclosures regarding fair value measurements are defined as a three-level valuation hierarchy for disclosure of fair value measurements as follows: Level 1 — Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date. Level 2 — Inputs (other than quoted market prices included in Level 1) are either directly or indirectly observable for the asset or liability through correlation with market data at the measurement date and for the duration of the instrument’s anticipated life. Level 3 — Inputs reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model. Valuation of instruments includes unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of assets or liabilities. The following is a summary of cash, cash equivalents and available-for-sale investments by type of instrument measured at fair value on a recurring basis (in thousands):
There were no significant transfers in and out of Level 1 and Level 2 fair value measurement categories during the three months ended June 30, 2016 and 2015. The following is a summary of the cost and estimated fair values of available-for-sale securities with stated maturities, which include U.S. Treasury and agency securities, corporate bonds, asset-backed and mortgage-backed securities and municipal bonds, by contractual maturity:
The following is a summary of gross unrealized losses (in thousands):
Accumulated other comprehensive loss:
Realized gain on short-term investments and interest income, net:
Net loss per share: Shares used in basic net loss per share are computed using the weighted average number of common shares outstanding during each period. Shares used in diluted net loss per share include the dilutive effect of common shares potentially issuable upon the exercise of stock options, purchase of Employee Stock Purchase Plan ("ESPP") rights and vesting of restricted stock units ("RSUs"). For the three months ended June 30, 2016 and 2015, the Company recorded a net loss. As such, all outstanding potential common shares were excluded from the diluted earnings per share computation. The following potentially dilutive common shares are excluded from the computation of net loss per share:
|
Veloce |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Business Combinations [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
VELOCE | VELOCE In June 2012, the Company completed the acquisition of Veloce Technologies, Inc. ("Veloce") which developed specific ARM-based technology for the Company. The total purchase consideration for Veloce was $178.5 million, the payment of which has been subject to the completion of certain development milestones and vesting requirements. For accounting purposes, the costs incurred in connection with the development milestones relating to Veloce were considered compensatory and recognized as R&D expense in the Condensed Consolidated Statement of Operations. Veloce completed the milestones as of March 31, 2014 and the total consideration of $178.5 million has been recognized as R&D expense as of March 31, 2015. The following table summarizes the cash payment and stock issuance activities as part of the above arrangement:
As of June 30, 2016, $171.9 million of the total Veloce consideration has been paid in cash and stock and the Company expects the remaining $6.6 million will be paid in cash and stock by September 30, 2016. The $171.9 million paid to date includes $89.4 million in cash and the issuance of 11.2 million shares of common stock valued at $82.5 million. |
Stockholders' Equity |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
STOCKHOLDERS' EQUITY | STOCKHOLDERS’ EQUITY Stock Options The Company has granted stock options to employees and non-employee directors under several plans. These option plans include two stockholder-approved plans (1992 Equity Incentive Plan and 2011 Equity Incentive Plan) and one plan not approved by stockholders (2000 Equity Incentive Plan). Options are fully vested generally in four years and expire eight to ten years from the effective date of grant. A summary of the Company's stock option activities and related information is as follows:
(1) The aggregate pre-tax intrinsic value is calculated as the difference between the market value on the date of exercise and the exercise price of the shares. (2) The aggregate pre-tax intrinsic value is calculated as the difference between the market value as of June 30, 2016 and the exercise price of the shares. The closing price of the Company’s common stock was $6.42 per share on June 30, 2016. Restricted Stock Units The Company has granted RSUs to employees and non-employee directors pursuant to its 2011 Equity Incentive Plan. RSUs are share awards that, upon vesting, will deliver to the holder shares of the Company’s common stock. RSUs vest over varying terms, to a maximum of four years from the date of the grant. In November 2013, May and October 2014, November 2015, and January and May 2016, the Compensation Committee (the "Committee") authorized market-performance based RSUs ("MSUs"). The MSUs will be earned, if at all, based on the Company's Total Shareholder Return (“TSR”) compared to that of the Standard & Poor's Depositary Receipts S&P Semiconductor Index ("Index”) over a two-year performance period for half of the MSU award and a three-year performance period for the remaining half of the MSU award. The MSUs will vest between ranges of 0% and 150% or 0% and 175% based on the Company's relative TSR compared to the Index. Total grant-date fair value of these MSUs was $4.7 million, of which $2.9 million expired unvested as of June 30, 2016. The Company has compensation programs with respect to fiscal 2016 and 2017. The programs include time-based RSUs and financial or operational performance-based awards with payouts that ranges from 0% to 150% of pre-established target levels. Awards under these programs vest in fiscal 2016 through 2018 and can be paid out in common stock or cash. A summary of the Company's RSU activities and related information is as follows:
The weighted average remaining contractual term for the RSUs outstanding as of June 30, 2016 was 1.3 years. As of June 30, 2016, the aggregate pre-tax intrinsic value of RSUs outstanding including performance-based awards which are subject to certain milestone attainments was $34.8 million. The aggregate pretax intrinsic value was calculated based on the closing price of the Company’s common stock of $6.42 on June 30, 2016. The aggregate pre-tax intrinsic value of RSUs released during the three months ended June 30, 2016 was $5.4 million. This intrinsic value represents the fair market value of the Company’s common stock on the date of release. Employee Stock Purchase Plan Under the Company's 2012 ESPP, the Company reserved 3.8 million shares for issuance. The ESPP provides that eligible employees may contribute up to 20% of their base salary, subject to certain limits, towards the purchase of the Company’s common stock. Under the terms of the ESPP, eligible employees are entitled to purchase common stock, on a semi-annual basis, at a purchase price equal to 85% of the fair market value of the common stock on the first or last day of the offering period, whichever is lower. At June 30, 2016, 1.2 million shares were available for future issuance under the ESPP. There were no stock purchases under the ESPP during the three months ended June 30, 2016 and 2015. |
Stock-Based Compensation |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
STOCK-BASED COMPENSATION | STOCK-BASED COMPENSATION The following tables summarize the allocation of the stock-based compensation expense:
As of June 30, 2016, the amount of unrecognized stock-based compensation cost related to unvested stock-based awards was $32.4 million which will be recognized over a weighted average period of 1.3 years. |
Commitments and Contingencies |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies | COMMITMENTS AND CONTINGENCIES Commitments The following table summarizes the Company's contractual operating leases and other purchase commitments as of June 30, 2016 (in thousands):
* Includes open purchase orders with terms that generally allow us the option to cancel or reschedule the order, subject to various restrictions and limitations. Also includes the licensing fees relating to the Company's R&D efforts, including IP, technology, product design, test and verification tools of $18.3 million. Warranty The Company's products typically carry a one-year warranty. The Company establishes reserves for estimated product warranty costs at the time revenue is recognized. Although the Company engages in extensive product quality programs and processes, its warranty obligation is affected by product failure rates, use of materials, and service delivery costs incurred in correcting any product failure. Historically, the Company’s warranty returns have not been material. Intellectual Property Indemnities The Company indemnifies certain customers and contract manufacturers against liability arising from third-party claims of IP rights infringement related to its products. These indemnities appear in development and supply agreements with customers as well as manufacturing service agreements with contract manufacturers and generally survive the expiration of the contract. Given that the amount of any potential liabilities related to such indemnities cannot be determined until an infringement claim has been made, the Company is unable to determine the maximum amount of losses that could be incurred related to such indemnifications. Guarantees and Indemnities In the normal course of business, the Company is occasionally required to provide other guarantees and indemnities for which it may be required to make future payments under specific circumstances. The amount of any potential liabilities related to such obligations cannot be accurately determined until a formal claim is filed. The Company maintains general and product liability insurance which may provide a source of recovery in the event of an indemnification claim. Legal Proceedings The Company is currently a party to certain legal proceedings, including those noted in this section. The Company believes the ultimate outcome of these proceedings, individually and in the aggregate, will not materially harm the Company's financial position, results of operations or cash flows. Notwithstanding the foregoing, legal proceedings are subject to inherent uncertainties, unfavorable rulings or other events that could occur. In addition, legal proceedings are expensive to prosecute and defend against and can divert management attention and Company resources away from the Company's business objectives. Unfavorable resolutions could include monetary damages against the Company or injunctions or other restrictions on the conduct of the Company’s business, or preclude the Company from recovering the damages it seeks in legal proceedings it has commenced. It is also possible that the Company could conclude it is in the best interests of its stockholders, employees, and customers to settle one or more such matters, and any such settlement could include substantial payments or the surrender of rights to collect payments from third parties. However, the Company has not reached this conclusion with respect to any material matter at this time. In 1993, the Company was named as a Potentially Responsible Party (“PRP”) along with more than 100 other companies that used an Omega Chemical Corporation waste treatment facility in Whittier, California (the “Omega Site”). The U.S. Environmental Protection Agency (“EPA”) has alleged that Omega failed to properly treat and dispose of certain hazardous waste materials at the Omega Site. The Company is a member of a large group of PRPs, known as the Omega Chemical Site PRP Organized Group (“OPOG”), which has agreed to fund certain on-going remediation efforts relating to the Omega Site. Pursuant to a consent decree entered into between EPA and OPOG and approved by the U.S. District Court for the Central District of California (the “Court”) in 2001, as amended in 2010, removal of waste materials stored at the Omega Site has been completed. Efforts to remediate the soil, groundwater and air quality at and around the Omega Site are expected to be ongoing for several more years. In addition, in April 2016 OPOG and EPA filed with the Court a consent decree (the “Consent Decree”) outlining the proposed remediation plan and related litigation settlement terms for a regional groundwater contamination plume allegedly originating at the Omega Site (the Operable Unit 2 or “OU2”). It is anticipated the Court will approve the Consent Decree in fiscal year 2017, following which remediation of OU2 will commence. It is also anticipated that the Court’s approval of the Consent Decree will cause it to lift the stay it had previously placed on litigation originally filed in 2007 by Angeles Chemical Company, located downstream from the Omega Site, against OPOG and the PRPs for cost recovery and indemnification for future costs allegedly resulting from OU2. In 2012, as a result of challenges made by certain PRPs to the criteria previously used to allocate liability among OPOG members, and of the departure of certain PRPs from OPOG, OPOG approved changes to the cost allocation structure that resulted in an increase to the Company's proportional allocation of liability. In 2013 and 2014, OPOG retained legal counsel to pursue groundwater remediation-related claims against other PRPs and to protect its interests in connection with bankruptcy proceedings filed by an OPOG member. In connection with those cost recovery efforts, in May 2014, OPOG entered into a cost sharing and settlement agreement (as amended in April 2016 in connection with the Consent Decree) with one PRP for future remediation costs and settlement of EPA’s past costs for OU2. To fund the shared costs, OPOG and the other PRP will create a Joint Environmental Remediation Trust, for which OPOG’s contribution amount will be funded from member assessments made in 2016. Any additional changes made to OPOG’s cost allocation structure, as well as the subsequent departure or bankruptcy of one or more other PRPs from OPOG, could have the effect of increasing the proportional liability of the remaining PRPs, including the Company. To date, the Company has remitted payments to OPOG covering its proportional allocation of liability for OPOG’s legal expenses and remediation costs; the Company's assessments received during fiscal year 2016 totaled approximately $62,000. The Company anticipates that its payment obligations relating to the Omega Site will increase once the Consent Decree receives final Court approval, although the timing of any such increases currently is uncertain. Notwithstanding such anticipated increases or their timing, the Company does not currently believe its total share of remediation-related expenses will be material to its financial statements, based on its approximately 0.5% contribution to the total waste tonnage sent to the site and current estimates of the potential aggregate remediation costs. Based on currently available information, the Company has a loss accrual that is not material and believe that the actual amount of our costs will not be materially different from the amount accrued. However, proceedings are ongoing and the eventual outcome of the clean-up efforts and the pending litigation matters is uncertain at this time. Based on currently available information, the Company does not believes that any eventual outcome will have a material adverse effect on its business or operations. |
Significant Customer and Geographic Information |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Significant Customer and Geographic Information | SIGNIFICANT CUSTOMER AND GEOGRAPHIC INFORMATION Based on direct shipments, net revenues to customers that were equal to or greater than 10% of total net revenues were as follows:
Based on ship to location, net revenues by geographic region were as follows:
As of June 30, 2016 and 2015, long-lived assets, which represent property, plant and equipment, goodwill and intangible assets, net of accumulated depreciation and amortization, located outside the Americas were not material. |
Summary of Significant Accounting Policies (Policies) |
3 Months Ended | ||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2016 | |||||||||||||||||||||||||||||||||
Accounting Policies [Abstract] | |||||||||||||||||||||||||||||||||
Basis of Presentation | Basis of Presentation The Condensed Consolidated Financial Statements include all the accounts of the Company's and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. The Company prepared the accompanying unaudited Condensed Consolidated Financial Statements pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). In management’s opinion, the unaudited Condensed Consolidated Financial Statements reflect all adjustments (consisting only of normal recurring adjustments) necessary to fairly present the Company's financial position, results of operations and cash flows. Interim period operating results do not necessarily indicate the results that may be expected for any other interim period or for the full fiscal year. These financial statements and accompanying notes should be read in conjunction with the Consolidated Financial Statements and notes thereto in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2016. |
||||||||||||||||||||||||||||||||
Use of Estimates | Use of Estimates The preparation of financial statements in accordance with U.S. generally accepted accounting principles ("GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of net revenue and expenses in the reporting period. The Company regularly evaluates estimates and assumptions related to its:
The Company bases its estimates and assumptions on historical experience and on various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from management’s estimates. To the extent there are material differences between the estimates and actual results, future results of operations will be affected. |
||||||||||||||||||||||||||||||||
Risk and Uncertainties | Risks and Uncertainties The Company's future results of operations involve a number of risks and uncertainties. Factors that could affect the Company's business or future results and cause actual results to vary materially from historical results include, but are not limited to, the highly cyclical nature of the semiconductor industry; high fixed costs; declines in average selling prices; ability to fund liquidity needs; failure to maintain an effective system of internal controls; product return and liability risks; absence of significant backlog; dependence on international operations and sales; proposed changes to United States tax laws which result in adverse tax consequences; inadequate management information systems; ability to attract and retain qualified employees; difficulties consolidating and evolving the operational capabilities; dependence on materials and equipment suppliers; loss of customers; development of new proprietary technology and the enforcement of intellectual property ("IP") rights by or against the Company; the complexity of packaging and test processes; competition; existing and future environmental regulations; and fire, flood or other calamities affecting the Company or others with whom it does business. The Company's cash, cash equivalents, short-term investments and accounts receivable are potentially subject to concentration of credit risk. Cash and cash equivalents may be redeemable upon demand and are maintained with several financial institutions that management believes are of high credit quality and therefore bear minimal credit risk. The Company's accounts receivables are derived from revenue earned from customers located around the world. Two customers accounted for 80% and 69% of accounts receivable at June 30, 2016 and March 31, 2016, respectively. This concentration and the concentration of credit risk resulting from trade receivables is substantially mitigated by the credit evaluation process and collateral. The Company sells its products primarily through direct sales force and distributors. Based on direct shipments, 2 and 4 customers individually accounted for at least 10% of total net revenues during the three months ended June 30, 2016 and 2015, respectively. The Company expects that its largest customers collectively will continue to account for a substantial portion of its net revenue for the foreseeable future. See Note 7, Significant Customer and Geographic Information, to the Condensed Consolidated Financial Statements for details. The Company currently purchases wafers from a limited number of vendors. Additionally, since the Company does not maintain manufacturing facilities, it depends upon close relationships with contract manufacturers to assemble its products. The Company anticipates the continued use of a limited number of vendors and contract manufacturers in the near future. Under the Company's fabless business model, long-term revenue growth is dependent on its ability to obtain sufficient external manufacturing capacity, including wafer production. The Company believes there are other vendors that can provide the same quality wafers at competitive prices and other contract manufacturers that can provide comparable services at competitive prices. N |
||||||||||||||||||||||||||||||||
New Accounting Pronouncements | New Accounting Pronouncements In March 2016, the FASB issued ASU No. 2016-09, "Stock Compensation (Topic 718); Improvements to Employee Share-Based Payment Accounting". The new guidance simplifies several aspects of the accounting for share-based payment transactions including the income tax consequences, classification of awards as either equity or liabilities, policy election to account for forfeitures as they occur rather than on an estimated basis, and classification on the statement of cash flows. The ASU is effective for annual periods beginning after December 15, 2016, including interim periods within that reporting period. Early adoption is permitted. The Company has adopted this ASU as of June 30, 2016. The adoption of this accounting standard was not material to the Company’s Condensed Consolidated Financial Statements and related disclosures. |
||||||||||||||||||||||||||||||||
Warrant, Intellectual Property Indemnities, Guarantees and Indemnities | Warranty The Company's products typically carry a one-year warranty. The Company establishes reserves for estimated product warranty costs at the time revenue is recognized. Although the Company engages in extensive product quality programs and processes, its warranty obligation is affected by product failure rates, use of materials, and service delivery costs incurred in correcting any product failure. Historically, the Company’s warranty returns have not been material. Intellectual Property Indemnities The Company indemnifies certain customers and contract manufacturers against liability arising from third-party claims of IP rights infringement related to its products. These indemnities appear in development and supply agreements with customers as well as manufacturing service agreements with contract manufacturers and generally survive the expiration of the contract. Given that the amount of any potential liabilities related to such indemnities cannot be determined until an infringement claim has been made, the Company is unable to determine the maximum amount of losses that could be incurred related to such indemnifications. Guarantees and Indemnities In the normal course of business, the Company is occasionally required to provide other guarantees and indemnities for which it may be required to make future payments under specific circumstances. The amount of any potential liabilities related to such obligations cannot be accurately determined until a formal claim is filed. The Company maintains general and product liability insurance which may provide a source of recovery in the event of an indemnification claim. |
Certain Financial Statement Information (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2016 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Certain Financial Statement Information [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Accounts receivable | Accounts receivable, net:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Inventories | Inventories:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Other current assets | Other current assets:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Property and equipment | Property and equipment:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Other accrued liabilities | Other accrued liabilities:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Cash, cash equivalents and available-for-sale investments by type of instruments | Short-term investments: The following is a summary of cash, cash equivalents and available-for-sale investments by type of instrument (in thousands):
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Cash, cash equivalents and available-for-sale investments by type of instruments measured at fair value on recurring basis | The following is a summary of cash, cash equivalents and available-for-sale investments by type of instrument measured at fair value on a recurring basis (in thousands):
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Cost and estimated fair values of available-for-sale securities with stated maturities by contractual maturity | The following is a summary of the cost and estimated fair values of available-for-sale securities with stated maturities, which include U.S. Treasury and agency securities, corporate bonds, asset-backed and mortgage-backed securities and municipal bonds, by contractual maturity:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Gross unrealized losses | The following is a summary of gross unrealized losses (in thousands):
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Accumulated other comprehensive loss | Accumulated other comprehensive loss:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Interest income, net | Realized gain on short-term investments and interest income, net:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of potentially dilutive common shares excluded from EPS computation | The following potentially dilutive common shares are excluded from the computation of net loss per share:
|
Veloce (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Business Combinations [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of cash payments and stock issuance activities | The following table summarizes the cash payment and stock issuance activities as part of the above arrangement:
|
Stockholders' Equity (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Option Activity Under Stock Incentive Plans | A summary of the Company's stock option activities and related information is as follows:
(1) The aggregate pre-tax intrinsic value is calculated as the difference between the market value on the date of exercise and the exercise price of the shares. (2) The aggregate pre-tax intrinsic value is calculated as the difference between the market value as of June 30, 2016 and the exercise price of the shares. The closing price of the Company’s common stock was $6.42 per share on June 30, 2016. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Restricted Stock Unit Activity | A summary of the Company's RSU activities and related information is as follows:
|
Stock-Based Compensation (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Stock-Based Compensation Expense of Stock Options and Restricted Stock Units | The following tables summarize the allocation of the stock-based compensation expense:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Stock-Based Compensation Expense |
|
Commitments and Contingencies (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Contractual Obligation by Fiscal Year Maturity | The following table summarizes the Company's contractual operating leases and other purchase commitments as of June 30, 2016 (in thousands):
* Includes open purchase orders with terms that generally allow us the option to cancel or reschedule the order, subject to various restrictions and limitations. Also includes the licensing fees relating to the Company's R&D efforts, including IP, technology, product design, test and verification tools of $18.3 million. |
Significant Customer and Geographic Information (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of net revenue by major customer | Based on direct shipments, net revenues to customers that were equal to or greater than 10% of total net revenues were as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of net revenue by geographic region | Based on ship to location, net revenues by geographic region were as follows:
|
Summary of Significant Accounting Policies - Additional Information (Details) |
3 Months Ended | 12 Months Ended |
---|---|---|
Jun. 30, 2016 |
Mar. 31, 2016 |
|
Customer Concentration Risk | Accounts Receivable | ||
Concentration Risk [Line Items] | ||
Concentration risk percentage | 80.00% | 69.00% |
Certain Financial Statement Information - Accounts Receivable (Details) - USD ($) $ in Thousands |
Jun. 30, 2016 |
Mar. 31, 2016 |
|||
---|---|---|---|---|---|
Schedule of Accounts receivable | |||||
Accounts receivable | $ 9,426 | $ 9,527 | |||
Less: allowance for bad debts | (263) | (262) | |||
Accounts receivable, net | $ 9,163 | $ 9,265 | [1] | ||
|
Certain Financial Statement Information - Inventories (Details) - USD ($) $ in Thousands |
Jun. 30, 2016 |
Mar. 31, 2016 |
|||
---|---|---|---|---|---|
Schedule of Inventories | |||||
Finished goods | $ 4,782 | $ 8,206 | |||
Work in process | 4,836 | 5,854 | |||
Raw materials | 2,986 | 2,088 | |||
Inventories, total | $ 12,604 | $ 16,148 | [1] | ||
|
Certain Financial Statement Information - Other Current Assets (Details) - USD ($) $ in Thousands |
Jun. 30, 2016 |
Mar. 31, 2016 |
|||
---|---|---|---|---|---|
Schedule of Other current assets | |||||
Prepaid expenses | $ 8,988 | $ 8,887 | |||
Executive deferred compensation assets | 837 | 817 | |||
Other | 1,081 | 1,071 | |||
Other current assets, total | $ 10,906 | $ 10,775 | [1] | ||
|
Certain Financial Statement Information - Property and Equipment (Details) - USD ($) $ in Thousands |
3 Months Ended | ||||
---|---|---|---|---|---|
Jun. 30, 2016 |
Mar. 31, 2016 |
||||
Schedule of Property and equipment | |||||
Machinery and equipment | $ 39,632 | $ 36,723 | |||
Leasehold improvements | 7,528 | 7,529 | |||
Computers, office furniture and equipment | 33,294 | 34,016 | |||
Property and equipment, gross | 80,454 | 78,268 | |||
Less: accumulated depreciation | (66,549) | (64,975) | |||
Property and equipment, net | $ 13,905 | $ 13,293 | [1] | ||
Machinery and Equipment | Minimum | |||||
Property, Plant and Equipment [Line Items] | |||||
Useful life (in years) | 3 years | ||||
Machinery and Equipment | Maximum | |||||
Property, Plant and Equipment [Line Items] | |||||
Useful life (in years) | 5 years | ||||
Leasehold Improvements | Minimum | |||||
Property, Plant and Equipment [Line Items] | |||||
Useful life (in years) | 1 year | ||||
Leasehold Improvements | Maximum | |||||
Property, Plant and Equipment [Line Items] | |||||
Useful life (in years) | 5 years | ||||
Computers, Office Furniture and Equipment | Minimum | |||||
Property, Plant and Equipment [Line Items] | |||||
Useful life (in years) | 3 years | ||||
Computers, Office Furniture and Equipment | Maximum | |||||
Property, Plant and Equipment [Line Items] | |||||
Useful life (in years) | 5 years | ||||
|
Certain Financial Statement Information - Other Accrued Liabiliteis (Details) - USD ($) $ in Thousands |
Jun. 30, 2016 |
Mar. 31, 2016 |
|||
---|---|---|---|---|---|
Schedule of other accrued liabilities | |||||
Employee related liabilities | $ 1,563 | $ 1,362 | |||
Executive deferred compensation | 871 | 848 | |||
Accrued bonus | 3,921 | 3,269 | |||
Other | 4,961 | 4,314 | |||
Total other accrued liabilities | $ 11,316 | $ 9,793 | [1] | ||
|
Certain Financial Statement Information - Short-Term Investments (Details) - USD ($) $ in Thousands |
Jun. 30, 2016 |
Mar. 31, 2016 |
Jun. 30, 2015 |
Mar. 31, 2015 |
|||
---|---|---|---|---|---|---|---|
Schedule of cash, cash equivalents and available-for-sale investments by type of instruments | |||||||
Available-for-sale Securities, Amortized Cost | $ 81,837 | $ 83,592 | |||||
Available-for-sale Securities, Gross Unrealized Gains | 492 | 288 | |||||
Available-for-sale Securities, Gross Unrealized Losses | (18) | (35) | |||||
Available-for-sale Securities, Estimated Fair Value | 82,311 | 83,845 | |||||
Cash and cash equivalents | 24,225 | 25,065 | [1] | $ 44,290 | $ 36,495 | ||
Short-term investments available-for-sale | 58,086 | 58,780 | [1] | ||||
Cash, Cash equivalents and Short-term investments, Estimated Fair Value | 82,311 | 83,845 | |||||
Cash | |||||||
Schedule of cash, cash equivalents and available-for-sale investments by type of instruments | |||||||
Cash and Cash equivalents, Estimated Fair Value | 21,219 | 23,510 | |||||
Cash equivalents | |||||||
Schedule of cash, cash equivalents and available-for-sale investments by type of instruments | |||||||
Cash and Cash equivalents, Estimated Fair Value | 3,006 | 1,555 | |||||
U.S. Treasury and agency securities | |||||||
Schedule of cash, cash equivalents and available-for-sale investments by type of instruments | |||||||
Available-for-sale Securities, Amortized Cost | 14,173 | 14,863 | |||||
Available-for-sale Securities, Gross Unrealized Gains | 74 | 38 | |||||
Available-for-sale Securities, Gross Unrealized Losses | 0 | (3) | |||||
Available-for-sale Securities, Estimated Fair Value | 14,247 | 14,898 | |||||
Corporate bonds | |||||||
Schedule of cash, cash equivalents and available-for-sale investments by type of instruments | |||||||
Available-for-sale Securities, Amortized Cost | 24,861 | 28,047 | |||||
Available-for-sale Securities, Gross Unrealized Gains | 338 | 221 | |||||
Available-for-sale Securities, Gross Unrealized Losses | 0 | (5) | |||||
Available-for-sale Securities, Estimated Fair Value | 25,199 | 28,263 | |||||
Asset-backed and mortgage-backed securities | |||||||
Schedule of cash, cash equivalents and available-for-sale investments by type of instruments | |||||||
Available-for-sale Securities, Amortized Cost | 16,701 | 13,565 | |||||
Available-for-sale Securities, Gross Unrealized Gains | 65 | 13 | |||||
Available-for-sale Securities, Gross Unrealized Losses | (18) | (27) | |||||
Available-for-sale Securities, Estimated Fair Value | 16,748 | 13,551 | |||||
Municipal bonds | |||||||
Schedule of cash, cash equivalents and available-for-sale investments by type of instruments | |||||||
Available-for-sale Securities, Amortized Cost | 1,877 | 2,052 | |||||
Available-for-sale Securities, Gross Unrealized Gains | 15 | 16 | |||||
Available-for-sale Securities, Gross Unrealized Losses | 0 | 0 | |||||
Available-for-sale Securities, Estimated Fair Value | $ 1,892 | $ 2,068 | |||||
|
Certain Financial Statement Information - Short Term Investments Fair Value (Details) - USD ($) $ in Thousands |
Jun. 30, 2016 |
Mar. 31, 2016 |
---|---|---|
Schedule of Cash, Cash Equivalents and Available-For-Sale Investments by Type of Instruments Measured at Fair Value on Recurring Basis | ||
Available-for-sale securities | $ 82,311 | $ 83,845 |
Cash | ||
Schedule of Cash, Cash Equivalents and Available-For-Sale Investments by Type of Instruments Measured at Fair Value on Recurring Basis | ||
Cash and cash equivalents | 21,219 | 23,510 |
Cash equivalents | ||
Schedule of Cash, Cash Equivalents and Available-For-Sale Investments by Type of Instruments Measured at Fair Value on Recurring Basis | ||
Cash and cash equivalents | 3,006 | 1,555 |
U.S. Treasury and agency securities | ||
Schedule of Cash, Cash Equivalents and Available-For-Sale Investments by Type of Instruments Measured at Fair Value on Recurring Basis | ||
Available-for-sale securities | 14,247 | 14,898 |
Corporate bonds | ||
Schedule of Cash, Cash Equivalents and Available-For-Sale Investments by Type of Instruments Measured at Fair Value on Recurring Basis | ||
Available-for-sale securities | 25,199 | 28,263 |
Asset-backed and mortgage-backed securities | ||
Schedule of Cash, Cash Equivalents and Available-For-Sale Investments by Type of Instruments Measured at Fair Value on Recurring Basis | ||
Available-for-sale securities | 16,748 | 13,551 |
Municipal bonds | ||
Schedule of Cash, Cash Equivalents and Available-For-Sale Investments by Type of Instruments Measured at Fair Value on Recurring Basis | ||
Available-for-sale securities | 1,892 | 2,068 |
Recurring | ||
Schedule of Cash, Cash Equivalents and Available-For-Sale Investments by Type of Instruments Measured at Fair Value on Recurring Basis | ||
Cash, cash equivalents and available-for-sale investments | 82,311 | 83,845 |
Recurring | Level 1 | ||
Schedule of Cash, Cash Equivalents and Available-For-Sale Investments by Type of Instruments Measured at Fair Value on Recurring Basis | ||
Cash, cash equivalents and available-for-sale investments | 38,472 | 39,963 |
Recurring | Level 2 | ||
Schedule of Cash, Cash Equivalents and Available-For-Sale Investments by Type of Instruments Measured at Fair Value on Recurring Basis | ||
Cash, cash equivalents and available-for-sale investments | 43,839 | 43,882 |
Recurring | Level 3 | ||
Schedule of Cash, Cash Equivalents and Available-For-Sale Investments by Type of Instruments Measured at Fair Value on Recurring Basis | ||
Cash, cash equivalents and available-for-sale investments | 0 | 0 |
Recurring | Cash | ||
Schedule of Cash, Cash Equivalents and Available-For-Sale Investments by Type of Instruments Measured at Fair Value on Recurring Basis | ||
Cash and cash equivalents | 21,219 | 23,510 |
Recurring | Cash | Level 1 | ||
Schedule of Cash, Cash Equivalents and Available-For-Sale Investments by Type of Instruments Measured at Fair Value on Recurring Basis | ||
Cash and cash equivalents | 21,219 | 23,510 |
Recurring | Cash | Level 2 | ||
Schedule of Cash, Cash Equivalents and Available-For-Sale Investments by Type of Instruments Measured at Fair Value on Recurring Basis | ||
Cash and cash equivalents | 0 | 0 |
Recurring | Cash | Level 3 | ||
Schedule of Cash, Cash Equivalents and Available-For-Sale Investments by Type of Instruments Measured at Fair Value on Recurring Basis | ||
Cash and cash equivalents | 0 | 0 |
Recurring | Cash equivalents | ||
Schedule of Cash, Cash Equivalents and Available-For-Sale Investments by Type of Instruments Measured at Fair Value on Recurring Basis | ||
Cash and cash equivalents | 3,006 | 1,555 |
Recurring | Cash equivalents | Level 1 | ||
Schedule of Cash, Cash Equivalents and Available-For-Sale Investments by Type of Instruments Measured at Fair Value on Recurring Basis | ||
Cash and cash equivalents | 3,006 | 1,555 |
Recurring | Cash equivalents | Level 2 | ||
Schedule of Cash, Cash Equivalents and Available-For-Sale Investments by Type of Instruments Measured at Fair Value on Recurring Basis | ||
Cash and cash equivalents | 0 | 0 |
Recurring | Cash equivalents | Level 3 | ||
Schedule of Cash, Cash Equivalents and Available-For-Sale Investments by Type of Instruments Measured at Fair Value on Recurring Basis | ||
Cash and cash equivalents | 0 | 0 |
Recurring | U.S. Treasury and agency securities | ||
Schedule of Cash, Cash Equivalents and Available-For-Sale Investments by Type of Instruments Measured at Fair Value on Recurring Basis | ||
Available-for-sale securities | 14,247 | 14,898 |
Recurring | U.S. Treasury and agency securities | Level 1 | ||
Schedule of Cash, Cash Equivalents and Available-For-Sale Investments by Type of Instruments Measured at Fair Value on Recurring Basis | ||
Available-for-sale securities | 14,247 | 14,898 |
Recurring | U.S. Treasury and agency securities | Level 2 | ||
Schedule of Cash, Cash Equivalents and Available-For-Sale Investments by Type of Instruments Measured at Fair Value on Recurring Basis | ||
Available-for-sale securities | 0 | 0 |
Recurring | U.S. Treasury and agency securities | Level 3 | ||
Schedule of Cash, Cash Equivalents and Available-For-Sale Investments by Type of Instruments Measured at Fair Value on Recurring Basis | ||
Available-for-sale securities | 0 | 0 |
Recurring | Corporate bonds | ||
Schedule of Cash, Cash Equivalents and Available-For-Sale Investments by Type of Instruments Measured at Fair Value on Recurring Basis | ||
Available-for-sale securities | 25,199 | 28,263 |
Recurring | Corporate bonds | Level 1 | ||
Schedule of Cash, Cash Equivalents and Available-For-Sale Investments by Type of Instruments Measured at Fair Value on Recurring Basis | ||
Available-for-sale securities | 0 | 0 |
Recurring | Corporate bonds | Level 2 | ||
Schedule of Cash, Cash Equivalents and Available-For-Sale Investments by Type of Instruments Measured at Fair Value on Recurring Basis | ||
Available-for-sale securities | 25,199 | 28,263 |
Recurring | Corporate bonds | Level 3 | ||
Schedule of Cash, Cash Equivalents and Available-For-Sale Investments by Type of Instruments Measured at Fair Value on Recurring Basis | ||
Available-for-sale securities | 0 | 0 |
Recurring | Asset-backed and mortgage-backed securities | ||
Schedule of Cash, Cash Equivalents and Available-For-Sale Investments by Type of Instruments Measured at Fair Value on Recurring Basis | ||
Available-for-sale securities | 16,748 | 13,551 |
Recurring | Asset-backed and mortgage-backed securities | Level 1 | ||
Schedule of Cash, Cash Equivalents and Available-For-Sale Investments by Type of Instruments Measured at Fair Value on Recurring Basis | ||
Available-for-sale securities | 0 | 0 |
Recurring | Asset-backed and mortgage-backed securities | Level 2 | ||
Schedule of Cash, Cash Equivalents and Available-For-Sale Investments by Type of Instruments Measured at Fair Value on Recurring Basis | ||
Available-for-sale securities | 16,748 | 13,551 |
Recurring | Asset-backed and mortgage-backed securities | Level 3 | ||
Schedule of Cash, Cash Equivalents and Available-For-Sale Investments by Type of Instruments Measured at Fair Value on Recurring Basis | ||
Available-for-sale securities | 0 | 0 |
Recurring | Municipal bonds | ||
Schedule of Cash, Cash Equivalents and Available-For-Sale Investments by Type of Instruments Measured at Fair Value on Recurring Basis | ||
Available-for-sale securities | 1,892 | 2,068 |
Recurring | Municipal bonds | Level 1 | ||
Schedule of Cash, Cash Equivalents and Available-For-Sale Investments by Type of Instruments Measured at Fair Value on Recurring Basis | ||
Available-for-sale securities | 0 | 0 |
Recurring | Municipal bonds | Level 2 | ||
Schedule of Cash, Cash Equivalents and Available-For-Sale Investments by Type of Instruments Measured at Fair Value on Recurring Basis | ||
Available-for-sale securities | 1,892 | 2,068 |
Recurring | Municipal bonds | Level 3 | ||
Schedule of Cash, Cash Equivalents and Available-For-Sale Investments by Type of Instruments Measured at Fair Value on Recurring Basis | ||
Available-for-sale securities | $ 0 | $ 0 |
Certain Financial Statement Information - Short-Term Investments Schedule of Maturities (Details) $ in Thousands |
Jun. 30, 2016
USD ($)
|
---|---|
Schedule of cost and estimated fair values of available-for-sale securities with stated maturities by contractual maturity | |
Less than 1 year, Cost | $ 13,471 |
Mature in 1 - 2 years, Cost | 34,118 |
Mature in 3 - 5 years, Cost | 8,823 |
Mature after 5 years, Cost | 1,200 |
Cost, Total | 57,612 |
Less than 1 year, Fair Value | 13,471 |
Mature in 1 - 2 years, Fair Value | 34,386 |
Mature in 3 - 5 years, Fair Value | 9,023 |
Mature after 5 years, Fair Value | 1,206 |
Fair Value, Total | $ 58,086 |
Certain Financial Statement Information - Short-Term Investments Gross Unrealized Losses (Details) - USD ($) $ in Thousands |
Jun. 30, 2016 |
Mar. 31, 2016 |
---|---|---|
Schedule of Gross Unrealized Losses | ||
Less Than 12 Months of Unrealized Losses, Estimated Fair Value | $ 22,391 | |
Less than 12 Months of Unrealized Losses, Gross Unrealized Losses | (35) | |
12 Months or More of Unrealized Losses, Estimated Fair Value | 0 | |
12 Months or More of Unrealized Losses, Gross Unrealized Losses | 0 | |
Total, Estimated Fair Value | 22,391 | |
Total Gross Unrealized Losses | (35) | |
U.S. Treasury and agency securities | ||
Schedule of Gross Unrealized Losses | ||
Less Than 12 Months of Unrealized Losses, Estimated Fair Value | 9,396 | |
Less than 12 Months of Unrealized Losses, Gross Unrealized Losses | (3) | |
12 Months or More of Unrealized Losses, Estimated Fair Value | 0 | |
12 Months or More of Unrealized Losses, Gross Unrealized Losses | 0 | |
Total, Estimated Fair Value | 9,396 | |
Total Gross Unrealized Losses | (3) | |
Corporate bonds | ||
Schedule of Gross Unrealized Losses | ||
Less Than 12 Months of Unrealized Losses, Estimated Fair Value | 4,601 | |
Less than 12 Months of Unrealized Losses, Gross Unrealized Losses | (5) | |
12 Months or More of Unrealized Losses, Estimated Fair Value | 0 | |
12 Months or More of Unrealized Losses, Gross Unrealized Losses | 0 | |
Total, Estimated Fair Value | 4,601 | |
Total Gross Unrealized Losses | (5) | |
Asset-backed and mortgage-backed securities | ||
Schedule of Gross Unrealized Losses | ||
Less Than 12 Months of Unrealized Losses, Estimated Fair Value | $ 4,681 | 8,394 |
Less than 12 Months of Unrealized Losses, Gross Unrealized Losses | (18) | (27) |
12 Months or More of Unrealized Losses, Estimated Fair Value | 0 | 0 |
12 Months or More of Unrealized Losses, Gross Unrealized Losses | 0 | 0 |
Total, Estimated Fair Value | 4,681 | 8,394 |
Total Gross Unrealized Losses | $ (18) | $ (27) |
Certain Financial Statement Information - Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands |
3 Months Ended | |||
---|---|---|---|---|
Jun. 30, 2016 |
Jun. 30, 2015 |
|||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
Beginning Balance | [1] | $ 115,038 | ||
Other comprehensive loss, net of tax | 2 | $ (1,790) | ||
Ending Balance | 110,931 | |||
Foreign currency translation adjustments | ||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
Beginning Balance | (2,486) | |||
Other comprehensive loss, net of tax | (145) | |||
Ending Balance | (2,631) | |||
Unrealized loss on short-term investments | ||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
Beginning Balance | (7,067) | |||
Other comprehensive loss, net of tax | 147 | |||
Ending Balance | (6,920) | |||
Total | ||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
Beginning Balance | (9,553) | |||
Other comprehensive loss, net of tax | 2 | |||
Ending Balance | $ (9,551) | |||
|
Certain Financial Statement Information - Realized Gain on Short-Term Investments and Interest Income, Net (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Jun. 30, 2016 |
Jun. 30, 2015 |
|
Schedule of Interest Income, Net | ||
Net realized gain on short-term investments | $ 32 | $ 1,430 |
Interest income, net | 198 | 189 |
Realized gain on short-term investments and interest income, net | $ 230 | $ 1,619 |
Certain Financial Statement Information - Potentially Dilutive Common Shares (Details) - shares shares in Thousands |
3 Months Ended | |
---|---|---|
Jun. 30, 2016 |
Jun. 30, 2015 |
|
Certain Financial Statement Information [Line Items] | ||
Dilutive securities excluded from the net loss per share computation | 7,187 | 5,959 |
Outstanding stock options | ||
Certain Financial Statement Information [Line Items] | ||
Dilutive securities excluded from the net loss per share computation | 1,384 | 1,713 |
Outstanding RSUs | ||
Certain Financial Statement Information [Line Items] | ||
Dilutive securities excluded from the net loss per share computation | 5,420 | 3,997 |
ESPP shares | ||
Certain Financial Statement Information [Line Items] | ||
Dilutive securities excluded from the net loss per share computation | 383 | 249 |
Veloce - Additional Information (Details) - Veloce Technologies Inc - USD ($) shares in Thousands, $ in Thousands |
1 Months Ended | 3 Months Ended | 49 Months Ended | |
---|---|---|---|---|
Jun. 30, 2012 |
Jun. 30, 2016 |
Jun. 30, 2015 |
Jun. 30, 2016 |
|
Business Acquisition [Line Items] | ||||
Total purchase consideration | $ 178,500 | $ 8 | $ 986 | $ 171,900 |
Consideration payable in cash or equity | 6,600 | 6,600 | ||
Cash payments | $ 8 | $ 65 | $ 89,400 | |
Stock issued (in shares) | 0 | 163 | 11,200 | |
Total equity value transferred | $ 82,500 |
Veloce - Cash Payments and Stock Issuances (Details) - Veloce Technologies Inc - USD ($) shares in Thousands, $ in Thousands |
1 Months Ended | 3 Months Ended | 49 Months Ended | |
---|---|---|---|---|
Jun. 30, 2012 |
Jun. 30, 2016 |
Jun. 30, 2015 |
Jun. 30, 2016 |
|
Business Acquisition [Line Items] | ||||
Cash payments | $ 8 | $ 65 | $ 89,400 | |
Value of common stock issued | 0 | 921 | ||
Total payments | $ 178,500 | $ 8 | $ 986 | $ 171,900 |
Shares of common stock issued (in shares) | 0 | 163 | 11,200 |
Stockholders' Equity - Stock Options (Details) $ / shares in Units, shares in Thousands, $ in Millions |
3 Months Ended | |||||
---|---|---|---|---|---|---|
Jun. 30, 2016
USD ($)
Approved_Plan
$ / shares
shares
| ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Number of stockholder-approved plans | Approved_Plan | 2 | |||||
Number of plans unapproved by stockholders | Approved_Plan | 1 | |||||
Schedule of Option Activity Under Stock Incentive Plans | ||||||
Number of Shares, Outstanding at the beginning of the year (in shares) | shares | 1,571 | |||||
Number of Shares, Granted (in shares) | shares | 0 | |||||
Number of Shares, Exercised (in shares) | shares | (6) | |||||
Number of Shares, Forfeited (in shares) | shares | (181) | |||||
Number of Shares, Outstanding at the end of the period (in shares) | shares | 1,384 | |||||
Number of Shares vested and exercisable at end of period (in shares) | shares | 1,384 | |||||
Schedule of Weighted Average Exercise Price Per Share Under Stock Incentive Plans | ||||||
Weighted Average Exercise Price Per Share, Outstanding at the beginning of the year (USD per share) | $ 8.92 | |||||
Weighted Average Exercise Price Per Share, Granted (USD per share) | 0.00 | |||||
Weighted Average Exercise Price Per Share, Exercised (USD per share) | 5.23 | |||||
Weighted Average Exercise Price Per Share, Forfeited (USD per share) | 11.56 | |||||
Weighted Average Exercise Price Per Share, Outstanding at the end of the period (USD per share) | 8.59 | |||||
Weighted Average Exercise Price Per Share, vested and exercisable at the end of the period (USD per share) | $ 8.59 | |||||
Weighted average remaining contractual term for options outstanding at end of period (in years) | 10 months 24 days | |||||
Weighted Average Remaining Contractual Life, vested and exercisable at end of period (in years) | 10 months 24 days | |||||
Aggregate pretax intrinsic value of options exercised | $ | $ 0.0 | [1] | ||||
Aggregate intrinsic value of options outstanding at end of period | $ | 0.0 | [2] | ||||
Aggregate intrinsic value of options, vested and exercisable at end of period | $ | $ 0.0 | [2] | ||||
Common stock, closing price per share (USD per share) | $ 6.42 | |||||
Stock options | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Vesting period, in years | 4 years | |||||
Stock options | Minimum | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Expiration period, in years | 8 years | |||||
Stock options | Maximum | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Expiration period, in years | 10 years | |||||
|
Stockholders' Equity - Restricted Stock Units (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions |
3 Months Ended | 31 Months Ended |
---|---|---|
Jun. 30, 2016 |
May 31, 2016 |
|
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] | ||
Common stock, closing price per share (USD per share) | $ 6.42 | |
Outstanding RSUs | ||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] | ||
Number of Shares, Beginning balance (in shares) | 4,704 | |
Number of Shares, Awarded (in shares) | 1,758 | |
Number of Shares, Vested (in shares) | (863) | |
Number of Shares, Cancelled (in shares) | (179) | |
Number of Shares, Ending balance (in shares) | 5,420 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] | ||
Weighted Average Grant Date Fair Value, Beginning Balance (in Dollars per share) | $ 6,590 | |
Weighted Average Grant Date Fair Value, Awarded (in Dollars per share) | 6,060 | |
Weighted Average Grant Date Fair Value, Vested (in Dollars per share) | 7,050 | |
Weighted Average Grant Date Fair Value, Cancelled (in Dollars per share) | 5,410 | |
Weighted Average Grant Date Fair Value, Ending Balance (in Dollars per share) | $ 6,380 | |
Weighted average remaining contractual term for the restricted stock units outstanding (in years) | 1 year 3 months 10 days | |
Aggregate pre-tax intrinsic value of restricted stock units outstanding which includes performance based awards which are subject to milestone attainments | $ 34.8 | |
Aggregate pretax intrinsic value | 5.4 | |
Performance-Based MSU | ||
Class of Stock [Line Items] | ||
Grants in period, fair value | $ 4.7 | |
Value of shares expired unvested in period | $ 2.9 | |
Performance-Based MSU | First Vesting period | ||
Class of Stock [Line Items] | ||
Award performance period | 2 years | |
Performance-Based MSU | First Vesting period | Minimum | ||
Class of Stock [Line Items] | ||
Vesting percentage | 0.00% | |
Performance-Based MSU | First Vesting period | Maximum | ||
Class of Stock [Line Items] | ||
Vesting percentage | 150.00% | |
Performance-Based MSU | Second Vesting Period | ||
Class of Stock [Line Items] | ||
Award performance period | 3 years | |
Performance-Based MSU | Second Vesting Period | Minimum | ||
Class of Stock [Line Items] | ||
Vesting percentage | 0.00% | |
Performance-Based MSU | Second Vesting Period | Maximum | ||
Class of Stock [Line Items] | ||
Vesting percentage | 175.00% | |
2011 Equity Incentive Plan | Outstanding RSUs | Maximum | ||
Class of Stock [Line Items] | ||
Vesting period, in years | 4 years | |
Compensation Programs | Minimum | ||
Class of Stock [Line Items] | ||
Award pay out percentage | 0.00% | |
Compensation Programs | Maximum | ||
Class of Stock [Line Items] | ||
Award pay out percentage | 150.00% |
Stockholders' Equity - Employee Stock Purchase Plan (Details) - Employee Stock Purchase Plan - 2012 Employee Stock Purchase Plan shares in Millions |
3 Months Ended |
---|---|
Jun. 30, 2016
shares
| |
Class of Stock [Line Items] | |
Common stock reserved for issuance (in shares) | 3.8 |
Maximum percentage of base salary that can be contributed to purchase common stock | 20.00% |
Percentage of purchase price of common stock equal to fair market value | 85.00% |
Shares available for future issuance (in shares) | 1.2 |
Stock-Based Compensation - Stock Based Compensation Expense (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Jun. 30, 2016 |
Jun. 30, 2015 |
|
Summary of Stock-Based Compensation Expense of Stock Options and Restricted Stock Units | ||
Stock-based compensation expense | $ 8,174 | $ 6,104 |
Stock-based compensation capitalized to inventory | (9) | (12) |
Total | 8,165 | 6,092 |
Cost of Revenues | ||
Summary of Stock-Based Compensation Expense of Stock Options and Restricted Stock Units | ||
Stock-based compensation expense | 167 | 105 |
Research and Development Expense | ||
Summary of Stock-Based Compensation Expense of Stock Options and Restricted Stock Units | ||
Stock-based compensation expense | 5,993 | 4,060 |
Selling, General and Administrative | ||
Summary of Stock-Based Compensation Expense of Stock Options and Restricted Stock Units | ||
Stock-based compensation expense | 2,014 | 1,939 |
Outstanding stock options | ||
Summary of Stock-Based Compensation Expense of Stock Options and Restricted Stock Units | ||
Stock-based compensation expense | 327 | 207 |
Outstanding RSUs | ||
Summary of Stock-Based Compensation Expense of Stock Options and Restricted Stock Units | ||
Stock-based compensation expense | $ 7,847 | $ 5,897 |
Stock-Based Compensation - Additional Information (Details) $ in Millions |
3 Months Ended |
---|---|
Jun. 30, 2016
USD ($)
| |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |
Unearned stock-based compensation | $ 32.4 |
Weighted-average period over which the unearned stock-based compensation is expected to be recognized, years | 1 year 3 months |
Commitments and Contingencies - Commitments (Details) $ in Thousands |
3 Months Ended | |||
---|---|---|---|---|
Jun. 30, 2016
USD ($)
| ||||
Operating Leases | ||||
2017 (remainder of year) | $ 1,849 | |||
2018 | 871 | |||
2019 | 503 | |||
Total | 3,223 | |||
Purchase Commitments | ||||
2017 (remainder of year) | 21,465 | [1] | ||
2018 | 11,194 | [1] | ||
2019 | 378 | [1] | ||
Total | 33,037 | [1] | ||
Total | ||||
2017 (remainder of year) | 23,314 | |||
2018 | 12,065 | |||
2019 | 881 | |||
Total | 36,260 | |||
Licensing Costs Due | $ 18,300 | |||
Length of warranty (in years) | 1 year | |||
|
Commitments and Contingencies - Contingencies (Details) $ in Thousands |
1 Months Ended | 3 Months Ended |
---|---|---|
Jan. 31, 2012 |
Jun. 30, 2016
USD ($)
Company
|
|
Commitments and Contingencies Disclosure [Abstract] | ||
Companies named as Potentially Responsible Parties (more than) | Company | 100 | |
Payments for OPOG's legal expenses and remediation costs | $ | $ 62 | |
Percent of contribution to the total waste | 0.50% |
Significant Customer and Geographic Information - Revenue by Customer (Details) - Net Revenue - Customer Concentration Risk |
3 Months Ended | |||
---|---|---|---|---|
Jun. 30, 2016 |
Jun. 30, 2015 |
|||
Wintec (global logistics provider) | ||||
Revenue, Major Customer [Line Items] | ||||
Concentration risk percentage | [1] | 26.00% | 29.00% | |
Avnet (distributor) | ||||
Revenue, Major Customer [Line Items] | ||||
Concentration risk percentage | 32.00% | 25.00% | ||
Arrow (distributor) | ||||
Revenue, Major Customer [Line Items] | ||||
Concentration risk percentage | 11.00% | |||
Flextronics (contract manufacturer) | ||||
Revenue, Major Customer [Line Items] | ||||
Concentration risk percentage | 11.00% | |||
|
Significant Customer and Geographic Information - Revenue by Geographical Location (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Jun. 30, 2016 |
Jun. 30, 2015 |
|
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Net revenues | $ 41,498 | $ 37,813 |
United States of America | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Net revenues | 18,239 | 18,044 |
Taiwan | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Net revenues | 2,649 | 1,314 |
Hong Kong | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Net revenues | 9,343 | 5,971 |
Europe | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Net revenues | 5,891 | 7,392 |
Japan | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Net revenues | 3,846 | 3,813 |
Other | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Net revenues | $ 1,530 | $ 1,279 |
*TE()8E1DC%*
M# *0,$(,$SU6D9(J4J."K#JJ,$@FDIB18: DRN&QDHQ4DIF*1DS5MX8)V((@
M(U0XDDD\L"D6L4
MDT$HRUS$ "T&S8J;; $>06\HMY 0X"^"(A=K:9*/Q1]L5ZUS2GJCL78?VPYX.V89,@<#>7M
MAIF; H 7BV">5.O3"$+[5(0P)SMTADIGXR* LZ
M<$?\;!4U*'D*5$'8JX7=)83C5=^_B8$LPNV,;LND3_8,H//?KQ%"96'D G@A
MT6\D= N88QF1M%2Z;_YR"0.YBDI0>V^Q"D)2DU(@69:ATW@S3S>QA;4QI8U*
M"ZS>@HW\7_C>DO#P#M13!Y''*JO28H,0/H9/D!;"P5C%09:*:AJ\16#?^$ !
M?6GFI-[[\K*/]7=X-.^"!&G2P0W #HZIA,!X_K;M?>$EP9Q/)EAN$*=#:9E=
M6;K(BZT76925#=X28L'+.;)-!.Q-TUD^Y/K-_^%T=<.(C (?2>@7JAC,\ >=>R!G_'36_+3WQ
M(+PU",$@- 9W&1O-Q- ,8+PXB5QW&LL!2Z:)
M-1"+!$TSFWXS;W&UV611T6A1D2EJ- N"M, @-%X20)L1:#(*&HV"3)3%3./0
MMXT# D4S?3,FB_"1K/%HUABRAC,=R8&9(=9 >"B8Z:MA//^1L,EHV,2$]69Z
M DSB1_]MXUR=7S5A1WUS<&M'3XV ,V%8'2ZG9U^=?W?KN;=
,]PA"M3H )
MWIT"18KBPQI-?0EQ2N)@*6EIGP-5$Y406\K]]<-W0
^OF)VN
M(_036M$B\!]Q"+[_@+FTZ<1_1^_TF9=T2G[W9&/6?4YWY]M]L?X7]CP*[>V#E JHI_3L;:,\>EFFC[D^);!X"P)F;Q.20[([K%$YMA,77G"-/>YZ>@O'N3BBY_\
M\H==YW1?<1I5L*IUP*\!GM4)_[#@Z&FJ!)\9&R5?3[=FYR?B?MY$=YA*T>K_
M@4]>V3SV>WII9)W,.3=.LP )5 W,=CH!)G+:6LS/'(:3##R'NJHV%HE#S2RW
MXNHQN/DFU/UA7<:X.XS$I^SF??DY1UJ635*\9RFRUCAXF,4.RO+PROG_:;V-
M4($G]7_-^3J?W-\"'#_41=3%&^DI0U?&+Z1J@AT&-\6.YM$A.T2Z-!YT%W3"
MJZIY=8F6[#"E1K&/-J*!=A]M3 ,5/]J8S=#SHTU7C;,?-K,J.Y(5>M,"0)
MWU+]7*DHE-]U^;[8_10Z;96ZO=MW%M[C=BRWATMADK Z6#1=S]2,Z+$%].#S
MNVS9UPCY5^=Y]4 U(]0"S3+HG[LE3M9DGN: L